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Abstract 
Cytochrome P450 reductase (CPR) is a mammalian enzyme that plays a crucial role in the 
metabolism of drugs and other xenobiotics. This diflavin reductase contains two essential 
flavin cofactors— flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN)—
each bound to a separate protein domain. CPR transfers two electrons sequentially from 
NADPH to the heme-iron of the cytochrome to support its monooxygenase reaction. My 
research is focused on elucidating CPR’s electron transport mechanism and the role of the 
FMN semiquinone (FMNsq, one-electron reduced species) in the process. Thus far, my 
efforts have focused on the Glycine-141 residue in the FMN-binding domain in CPR.  This 
residue is thought to be a critical component in preserving a unique and stabilizing 
hydrogen bond with the N(5)H group of the neutral FMNsq state.  Through the process of 
site-directed mutagenesis, Glycine-141 has been replaced by a threonine (G141T) and an 
alanine (G141A, which I personally generated). More recently, this residue has been deleted 
(G141del) from the loop it occupies in an attempt to alter the conformation of this loop and 
to disrupt this crucial interaction with the cofactor. Each Glycine-141 alteration is theorized 
to affect the stability of the FMN semiquinone, as evidenced primarily by changes in the 
electron transfer between the domains of CPR. The primary goal of my research project, 
therefore, is to characterize how the alterations in the mutant CPR varieties affect the 
kinetics of electron transfer.  
 Following the generation of each mutant, the protein was expressed in culture, 
purified (using affinity chromatography) and finally characterized (using SDS-PAGE analysis, 
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as well as high performance liquid chromatography (HPLC)). Additionally, a series of 
analytical assays were performed to gain insight into the effects of the Glycine-141 
alteration. The first analytical experiments that were performed were steady-state turnover 
(SSTO) assays, which provide an overall rate of electron transfer through CPR (from the 
NADPH electron donor to a cytochrome c electron acceptor). Essentially these experiments 
assessed the activity of the proteins and confirmed, to a certain degree, that all CPR 
varieties were folded correctly and functioning properly. Upon analyzing the procured 
turnover data, it was determined that there were, at a cursory level, significant kinetic 
differences between the Glycine-141 altered mutant CPR variants and wild-type CPR (WT 
CPR). Oxidative titrations of the CPR varieties with ferricyanide were then performed to 
establish the level of FMN semiquinone formation among the CPR varieties. These 
experiments permit for the controlled removal of electron equivalents from the CPR system 
which allows specific observance of pre-identified redox species of CPR.  Again there were 
significant differences in the amount of semiquinone formed in WT CPR, G141A, G141T, and 
G141del CPR. The focus of my research then became elucidating the specific mechanistic 
differences causing these changes in CPR characteristics and how the changes in stability in 
the FMNsq accounted for these kinetic discrepancies.  
 Two major methods were utilized to elucidate the mechanism of electron transfer in 
CPR: pre-steady state turnover (pre-SSTO) assays and using iterative exponential and global 
data fitting along with kinetics modeling software to acquaint our kinetic data to specific 
biochemical steps. Pre-steady state turnover assays are performed using a stopped-flow 
spectrophotometer, which allows for a reaction to be monitored within the first couple 
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milliseconds of mixing two solutions, and is therefore a valuable tool in characterizing CPR 
activity which occurs very quickly. The majority of my research effort is focused on 
establishing the inter-flavin electron transfer characterization of WT CPR, G141A CPR, 
G141T CPR and G141del CPR during reductive and oxidative half-reactions in these pre-
steady-state turnover assays. Reductive half reactions consist on looking at the transfer of 
electrons from bound NADPH to the FAD domain of CPR and then from the FAD domain to 
the FMN domain of CPR. This absorbance plot of the reductive half reaction was observed 
to be triphasic. The first kinetic phase, which is the rate of hydride transfer from NADPH to 
the FAD, was not appreciably affected by alterations.  However, the first observed species is 
the disemiquinoid form (each flavin contains one electron) indicating that inter-flavin 
electron transfer is more rapid.  The second phase appears also to be associated with inter-
flavin transfer and is dependent on NADP+ and the alteration. In the deletion variant, this 
phase is associated with the more rapid loss of the disemiquinoid species, consistent with 
its instability. The third, previously unrecognized, phase was not appreciable affected by the 
Glycine-141 alterations and may be too slow to be catalytically relevant. The data supports 
our hypothesis that the unique FMN-binding loop in CPR plays a significant role in its 
electron-transferring activity and serves to help clarify the specific mechanistic steps in the 
electron transfer process in diflavin reductases. To complement this reductive half reaction 
data, oxidative half-reactions, which consist of watching electrons move from the FAD 
domain to the FMN domain of CPR and finally to a final cytochrome c electron acceptor, 
were be performed. Effectively, analysis of this oxidative half-reaction experiment allow us 
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to dissect the overall electron transfer from CPR to cytochrome c into individual steps, 
much like we did with the reductive half reaction.  
 The absorbance change plots from these pre-steady state turnover experiments are 
often difficult to understand. The most reasonable way to acquaint our kinetic data to 
specific biochemical events will be to model reaction mechanisms using kinetic simulation 
software, which allows for the fitting of experimentally acquired data to pre-constructed 
species-based models. This technique will allow us to make models of the reductive and 
oxidative half-reactions and relate observed absorbance changes to specific rates of 
electron transfer between redox species of CPR. After a prototypical model of electron 
transfer has been made for wild-type CPR, then application of the model to the data of the 
G141A, G141T and G141del CPR oxidative and reductive half-reactions will allow us to 
identify more precisely how the alteration in the FMN-binding domain is affecting the 
electron transfer in CPR. The effectiveness of this modeling software has been proven in our 
preliminary analysis of the reductive half-reaction data of all CPR varieties, which has 
generated a better understanding of the experimental data. Our original kinetic model 
(acquired from literature and experimental inference) for the reduction and interflavin 
electron transfer of CPR with stoichiometric amounts of NADPH consisted of five species 
and could account for only the initial reactionary phase in the triphasic reactionary curve 
seen in the pre-SSTO reductive half-reactions. From this initial construct, I worked 
methodically building in new species to create a model that would not only allow the KinTek 
software to fit the kinetics data for WT, G141A, G141T and G141del CPR, but also be able to 
account for varying reactionary conditions (in particular changing levels of NADP+ in 
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solution, a variable which had been shown to affect the rate of reduction and shape for 
kinetics traces, presumably due to competitive binding with NADPH to CPR). After some 
time, we had developed a full model for the 2-election reduction of CPR with NADPH which 
consisted of nine species. To help fill out this mechanism, additional stopped-flow 
spectrophotometric pre-SSTO reductive assays were performed on WT CPR and G141del 
CPR with varying levels of NADP+ and the model was modified to fit these data sets. 
Currently, our model for the electron transfer in CPR can accurately fit data sets from every 
CPR variety and could be called roughly complete. From the model, we have already 
acquired some new insights. Primarily, our model supports the idea that the first observed 
phase in the reductive half-reaction of CPR is the rate hydride transfer from NADPH. 
Secondly, the observed rate of the secondary phase of the reactionary trace seems not to 
be associated with a single electron transfer step, but rather is just the apparent rate of a 
number of steps and the product of several microscopic rate constants. This secondary 
phase seems to be the related release of NADP+ from CPR species at varying degrees of 
flavin reduction (disemiquinoid and FMN fully reduced in particular). In essence, the release 
of NADP+ creates multiple species which have the same absorption character, allowing for 
the appearance of a bi- or triphasic curve in the reductive process. Additionally, the rate 
release of NADP+ appears to be somewhat correlated to the Glycine-141 alteration, an 
unexpected finding that I am currently investigating. Finally, the competitive binding of 
NADP+ and NADPH seems to be a significant occurrence as demonstrated by the changes in 
reactionary trace at high NADP+ concentrations. 
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 Seeing the efficacy of the kinetic model and understanding the complex 
experimental data my current and future research efforts will be to continue working on the 
reductive half-reaction, as well as, to develop a similar model for the oxidative half-reaction. 
This process will undoubtedly involve a number of additional clarifying and exploratory 
experiment to confirm the validity of the theoretical mechanism under differing or untested 
reaction conditions. However, the final product of this data analysis is a thorough model of 
electron transfer in cytochrome P450 reductase and upon comparison of electron transfer 
rates between the CPR mutants; we will have a substantial understanding of the role of the 
Glycine-141 residue and the FMN semiquinone state in the electron transfer process. 
 The significance of this research project revolve around cytochrome P450 
reductase’s role in the oxidative metabolism drugs, xenobiotics, and endogenous 
compounds in the endoplasmic reticulum of cells. The metabolism of all of these molecules 
is actually performed by the monooxygenase activity of cytochromes P450, but for these 
proteins to be enzymatically active, they require the addition of two consecutive electrons. 
This reduction process is performed primarily by CPR and therefore the electron transfer 
mechanism that we are studying has implications in better understanding of pharmaceutical 
design and breakdown, cellular catabolism of toxins and vitamins, and physiological 
oxidative metabolism as a whole. Additionally, this project could have benefits to the 
specific biochemical field of flavoprotein research. Cytochrome P450 reductase is a 
prototypical diflavin reductase enzyme, so mechanistic understanding of this protein could 
help in the understanding of other diflavin reductases including nitric oxide synthase (NOS), 
a cancer cell protein (NR1), subunits of bacterial sulfite reductases (SiR), and the 
8 
 
flavoprotein domain of flavocytochrome P450BM-3 (which is a bacterial enzyme also 
studied in the Swenson lab). Although all of these enzymes are different in structure, their 
operating mechanism cannot be too varied because they electron transfer proceeds 
through the flavin cofactors. That said, understanding the kinetics of one of these diflavin 
reductases could augment understanding of this entire class of proteins. 
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Introduction 
The physiological role of cytochrome P450 reductase: Cytochrome P450 reductase (CPR) serves 
as an electron donor to the microsomal cytochrome P450 dependent monooxygenase system 
[2]. The cytochrome P450 system is composed CPR and cytochrome P450 (CYP), both of which 
are integrated into the endoplasmic reticulum of liver cells primarily. The role of CPR in this 
system is to transfer two electrons from a bound NADPH molecule to a cytochrome P450 as the 
final electron acceptor.  The transfer occurs in a sequential one-by-one fashion (see Figure 1). 
Overall, the cytochrome P450 system functions primarily to oxidize xenobiotic chemicals and, to 
a lesser degree, synthesize endogenous compounds [3,5].  
 Cytochrome P450s are common throughout nature, but their function varies depending 
on the enzymatic system they are a part of. CYP genes are present in many diverse eukaryotes 
and in different quantities. The prevalence of CYP genes is most extensive in higher order plant 
species like the thale cress (Arabidopsis thaliana) and the rice plant (Oryza sativa) which have 
249 and 323 CYP genes, respectively. In addition, these higher order plants can have 2 or 3 
isotypes of cytochrome P450 reductase which have differing reduction-oxidation (redox) 
properties and sub-cellular distribution. This accounts for the greater functionality of plant CYP 
systems in the areas of coloration, detoxification, and biosynthesis [5,7]. In contrast, animals 
have less extensive arrays of CYP genes.  For example, whereas mice (Mus musculus) have 102 
putatively functioning full length CYP genes, fruit flies (Drosophila melanogaster) have 84, 
humans have 57, and Baker’s yeast (Saccharomyces cerevisiae) has a mere 3 CYP genes. There is 
only one isotype of cytochrome P450 reductase gene in animals which supports catalysis of 
many cytochrome P450s and, in microsomes, it has been shown that the molar ratio of CPR to  
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Figure 1 – This cartoon shows the general electron transfer mechanism from cytochrome P450 
reductase (including transfer within CPR) to cytochrome P450. 
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CYP is about 5-10 to 1 [5,6,7]. CPR acts as the primary reductant of the cytochrome P450 
system and, therefore, understanding of CPR activity has vast implications across a large variety 
of eukaryotic species.  
Degradation of xenobiotics is the primary action of the cytochrome P450 system and to 
a lesser degree the synthesis of certain endogenous chemicals. In terms of synthesis, CYP has 
been implicated in the production of steroids, eicosanoids, bile acids, prostaglandins, and 
vitamins D3 [3,5]. The majority of the biochemical processes are performed by cytochrome 
P450 systems in the inner membrane of the endoplasmic reticulum of liver cells; however, 
there are a small number of CYP enzymes located in the mitochondria. It is also theorized that 
limited numbers of CYPs are transported to the plasma membrane where they are exposed 
extracellularly and can participate in immune response development caused by anti-
microsomal autoantibodies [5,8].  Despite the cellular localization, the primary role of the 
cytochrome P450 system is to catalyze the oxidation of xenobiotic chemicals. Xenobiotics are, 
very generally, substances found in an organism which are not normally found there and either 
have some medicinal value or no functional value. Xenobiotics that are water-soluble can 
typically be excreted in feces or urine without chemical modification. Most xenobiotics, 
however, are hydrophobic (lipid-soluble) and therefore harder to excrete and these substances 
are toxic at high enough concentrations [3,5]. Therefore, complex systems to make xenobiotics 
water soluble have been evolved and the cytochrome P450 system is a prototypical example. 
CYP enzymes are involved in the metabolism of such substances as carcinogens, pesticides, fat-
soluble vitamins, steroids, eicosanoids, alkaloids, and drugs; just to name a very few [5]. Drug 
metabolism by cytochrome P450 enzymes has been a topic of intense interest by 
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pharmaceutical companies for three reasons. First, P450 catalysis lowers the bioavailability of 
the drug in the plasma and at the target site (problems in bioavailability is one of the most 
prevalent reasons for failure in drug discovery). Secondly, cytochrome P450 monooxygenases 
can convert pro-drugs to their active form through oxidation activity. Such effects are being 
taken advantage of in the design of bioreductive drugs, which play off a predictable 
degradation patterns to activate drugs.  Also, gene therapies can be used to insert cytochrome 
P450 genes into tumor cells to make them targets for anti-cancer pharmaceuticals. Finally, the 
P450 catalysis could degrade drugs to inactive forms or, conversely, degrade other xenobiotics 
which covalently bind to macromolecules or interact with an unintended molecular target to 
cause toxicity [3,4,5]. These actions of cytochrome P450 systems are crucial for understanding 
better pharmaceutical design and xenobiotic degradation in general. 
 The reaction performed by the cytochrome P450 (a heme-based monooxygenase 
reaction) can be generally classified as a mixed-function oxidation, which causes the insertion 
of one oxygen atom from molecular oxygen into the substrate with the byproduct of water 
derived from the other oxygen atom (equation 1) [3,5]: 
(1) NADPH + H+ + O2 + R → NADP
+ + H2O + RO 
The widely accepted catalytic cycle for cytochrome P450 can be seen in Figure 2.  In particular 
for this thesis, it is of importance to look at the role of cytochrome P450 reductase. In step 1, 
the substrate binds to CYP, with the iron in the ferric state, then in step 2 CPR transfers a single 
electron (from NADPH to FAD to FMN) directly to the heme of CYP to take the iron to the 
ferrous state. Then ferrous CYP binds O2 in step 3 and in step 4 CPR donates a second electron 
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into the system, but in some cases this electron may be transferred through a cytochrome b5 
intermediate. This is not that outlandish because CPR has been shown to reduce a multitude of 
other enzymes including squalene monooxygenase, heme oxygenase, and cytochrome b5 in 
separate reactions [5,6,7]. Either way, it is important to note that the electrons are transferred 
from CPR to CYP in a sequential one-by-one fashion (this will be described later in more detail). 
Continuing, in step 5 a proton is added to CYP which leads to the formation of H2O and ferric 
CYP in step 6 following the cleavage of the O-O bond. In step 7, a hydrogen atom or an electron 
is added into the system from the substrate and then this intermediate generates the product 
of step 8 which is released in step 9 [5]. The reaction of cytochrome P450 is technically only the 
first of three steps in the metabolism of xenobiotics, that is, the activation of the compound. 
Following activation of the compound, reactive groups are inactivated, and finally the product is 
conjugated with highly hydrophilic compounds to make the complex water soluble and able to 
be secreted [3]. 
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Figure 2- Cytochrome P450 Catalytic Cycle.  
Recreated from F.P. Guengerich (Reference 5). 
 
 
 
 
18 
 
The structure of cytochrome P450 reductase: The monooxygenase reaction of cytochrome P450 
depends on the transfer of electrons, either directly or indirectly, from cytochrome P450 
reductase, therefore understanding of the important structural features of CPR that are 
responsible for this efficient electron transfer is of importance. CPR is a prototypical diflavin 
reductase and contains two essential flavin cofactors—flavin adenine dinucleotide (FAD) and 
flavin mononucleotide (FMN)—each bound to a separate domain.  Overall this 78 kilodalton 
(kDa) protein is comprised of four distinct structural domains which form two primary 
“functional” domains *1,10]. From the N-terminus to C-terminus: the single CPR polypeptide 
forms a 56-residue (6 kDa) hydrophobic anchor which secures the protein to the endoplasmic 
reticulum, followed by a FMN-binding domain, a short flexible linker region, and finally a FAD- 
and NADPH-binding domain (in this paper, the latter two structural domains will be referred to 
functionally as the FAD-binding domain) [9,10]. It is important to note that for the bulk of the 
discussion in this thesis “CPR” will refer to “solubilized CPR”, representing the recombinant 
form of the protein without the hydrophobic membrane anchor. This 72 kDa form of CPR has 
very similar function to the natural form, but the truncated enzyme cannot transfer electrons to 
membrane-associated cytochrome P450s, although cytochrome c is able to serve as a final 
electron acceptor and is widely used and accepted as an expedient surrogate for experimental 
studies [6,10]. Cytochrome c (cyt c) is similar in structure and biochemical function to 
cytochrome P450 with the exception that it is a one-electron acceptor, whereas, the oxygen 
complex of cytochrome P450 is a two-electron acceptor. The FMN- and FAD-binding domains 
are the functional domains of the protein that allow for the transfer of electrons from the 
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bound NADPH to the final electron acceptor.   Electron transfer occurs from the NADPH to the 
FAD cofactor and then the FMN which serves as the electron donor to the cytochrome.   
The FMN-binding domain forms a canonical flavodoxin-like motif consisting of a five–
stranded parallel β-sheet sandwiched between α-helices [1,10,25]. The FMN cofactor is bound 
in a mainly hydrophobic pocket at the C-terminal of the domain.  This binding site is comprised 
of the polypeptide fragments 139TYGEGPD and 175NKTYEHFN with the isoalloxazine ring of the 
FMN forming a π- π stacking interactions with the aromatic resides Tyr140 and Tyr178 on the 
re-side and si-side, respectively [6,10]. Additionally, the FMN-binding domain contains a “bowl” 
provided by β4-α6 and β5-α7 peptide loops, which allow for maximal contact between the 
positively charged cytochrome c surface and the negatively charged FMN surface, presumably 
holding the cytochrome c (or cytochrome P450) in proper place for electron transfer [16]. After 
the FMN-binding domain, there is a connection mainly composed of α-helices, which couples 
the FMN- and FAD-binding domains and is also responsible, along with a 117 residue α-helical 
insertion in the FAD-binding domain, for bringing the two isoalloxazine rings of the flavin 
cofactors into a “continuous ribbon” conformation that is about 3.5 Å apart with an angle of 
about 150° to each other. This proximity allows for effective and direct electron transfer (see 
Figure 3) [6,10,11]. Another critical action of this connection domain is the formation of a 
“hinge” between this connection domain and the FMN-binding domain of CPR which, judging 
from the lack of resolution in crystallographic studies, allows the FMN-binding domain, and the 
FMN cofactor, a substantial amount of conformational motility assumed to aid in electron 
transfer [10]. Following this connector sequence is the FAD- and NADPH-binding domains. The 
FAD-binding domain is a flattened anti-parallel β-barrel and, furthest C-terminal, the NADPH-
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binding domain is another parallel five-stranded β-sheet sandwiched between α-helices (see 
Figure 4 for full CPR structure) [6,10]. The FAD cofactor is bound, in extended confirmation, by 
polypeptide fragments 455YYSIAS and 471ICAVAV with the isoalloxazine inserted in the boundary 
of the FAD- and NADPH-binding domains and the remainder of the FAD molecule bound 
between the FAD-binding domain and the connecting domain. Like in the FMN cofactor, the 
isoalloxazine ring forms π- π stacking interactions, on the re-side with the indole ring of the 
Trp677 residue and on the si-side with the Tyr456 residue [10,25]. The nicotinamide portion of 
NADP+ molecule, bound to the NADPH-binding domain does not show high resolution in 
crystallographic studies, demonstrating that there are possible multiple conformations based 
on 120° rotations around the pyrophosphate bond in bound NADP+. The finding of 
conformational changes has lead to the hypothesis that the binding of NADPH and rotation 
around the pyrophosphate (Pn-O-Pa) bond would allow the reduced nicotinamide to displace 
the Trp677 residue on the re-side of the FAD cofactor allowing direct hydride transfer from 
NADPH to N5 position of the FAD [6].   
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Figure 3- Orientation of CPR cofactors FMN (flavin mononucleotide) and FAD (flavin adenine 
dinucleotide) and the CPR coenzyme NADP (nicotinamide adenine dinucleotide phosphate). 
Recreated from M.B. Murataliev et al. (reference 6). 
 
 
Figure 4- Ribbon diagram showing the structure of CPR. The FMN-binding domain is in blue, the 
connecting-domain is shown in maroon, and the FAD- and NADPH-binding domains are shown 
in green. The disordered hinge region is in pink and labeled “hinge”. Enzyme cofactors are in 
ball-and-stick form and FMN is blue, FAD is yellow and NADP+ is in orange. 
Recreated from M. Wang et al. (reference 10) 
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 Cytochrome P450 reductase is a typical diflavin reductase, as can be seen in the 
structure, because the fused two functional domains of electron transfer are integrated with 
the flavin cofactors FAD and FMN. Besides CPR, there is an entire family of diflavin reductases 
including: bacterial sulfite reductase (SR), methionine synthase reductase (MSR), nitric oxide 
synthase (NOS), and human novel reductase 1 (NR1) [6,22,25]. Related to this family are further 
evolved complex multi-domain enzymes which have incorporated the heme-containing 
oxygenase component with the diflavin reductase. These include the bacterial flavocytochrome 
P450BM-3 (BM-3) and the P450 fatty acid hydroxylases [11,12,22]. The relatedness of these 
proteins provides a motivation for studying CPR because although all of these enzymes are 
different in structure, their electron transfer mechanisms are likely to share similarities as they 
all involve two flavin cofactors. That said, understanding the kinetics of one of these diflavin 
reductases could augment understanding of this entire class of proteins.  
The evolution of cytochrome P450 reductase has been a topic of interest, most 
probably, due to the fact that understanding the formative components of this fusion enzyme 
could help elucidate the mechanism of the whole enzyme. Through sequence and structural 
studies it has been suggested that CPR and other diflavin reductases are the result of a fusion 
between the ancestral genes of a ferrodoxin-NADP+ reductase (FNR) and a flavodoxin. The 
FMN-binding domain is homologous to the Desulfovibrio vulgaris flavodoxin, which is a well-
characterized FMN-dependent low potential electron transferase involved in the catalysis of 
electron transfer in many systems [1,6]. This flavodoxin displays considerable structural 
homology to the FMN-binding domains of several diflavin reductase and CPR in particular. FNR 
is an example of a transhydrogenase-type flavoprotein, which catalyze electron transfer 
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between a nicotinamide cofactor and a one-electron acceptor or donor protein [2,21]. 
Comparison of the FAD-binding domain of CPR to FNR shows a great deal similarity (especially if 
a 117-residue insert is added in the middle of the FAD-binding domain). Also, structural and 
sequence comparison of the FAD-binding domain to other transhydrogenase-type flavoproteins 
such as cytochrome b5 reductase (b5R) and glutathione reductase (GR) show that FNR, b5R, GR, 
and CPR’s FAD domain are homologous *1,2+. The similarity of these proteins suggest that 
flavodoxin and FNR genes may have been arranged in the same operon, or in close genomic 
position, and an alteration event eventually linked the two protein into an ancestral form of 
CPR (see Figure 5). A similar fusion event could even be seen happening between CPR and 
cytochrome P450 genes to create cytochromes P450BM-3 and P450 fatty acid hydroxylases. 
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Figure 5- A cartoon of the gene fusion of D.sulfibrio flavodoxin and ferrodoxin-NADP+ reductase 
into a single polypeptide of cytochrome P450 reductase 
Recreated from M.B. Murataliev et al. (Reference 6) 
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Mechanism of electron transfer in CPR: The basic mechanism for electron transfer in 
cytochrome P450 reductase is pretty well understood; a molecule of NADPH binds to the FAD-
binding domain of CPR, followed by an obligatory two electron hydride transfer to the FAD.  
The two electrons are then thought to be transferred in two sequential one-electron steps to 
the cytochrome P450 via the FMN domain (see Figure 1). The reaction catalyzed by CPR is 
shown by equation 2 [6,14]: 
(2) NADPH + 2Ao  NADP
+ + 2Ar + H
+  
where Ao and Ar represent the electron acceptor in the oxidized and reduced forms, 
respectively. And, as was previously mentioned, the physiological final electron acceptor is 
most often cytochrome P450 or cytochrome b5, where electron transfer supports 
monooxygenase reactions. Other “artificial” electron acceptors are commonly used and 
accepted for in vitro studies such as cytochrome c and potassium ferricyanide.  
 Looking more specifically at the mechanism of CPR, the reductase has two substrates, 
NADPH and the terminal electron acceptor, and two products, NADP+ and the reduced electron 
acceptor. Both Ping-Pong and sequential Bi-Bi mechanisms have been used to classify two-
substrate enzymes [6]. In the Ping-Pong mechanism, the first product is released from the 
modified enzyme before a second substrate binds (see Figure 6a). Typically, enzymes that 
proceed by Ping-Pong mechanisms have two substrates binding at the same site or overlapping 
sites. However, inspection of the structure of CPR casts doubt on this mechanism because 
NADPH binds to the FAD-binding domain and oxidized cytochrome c or cytochrome P450 very 
likely binds to the FMN-binding domain given that this domain is essential for electron transfer 
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to the cytochrome. Therefore, a more appealing mechanism is a sequential Bi-Bi mechanism, in 
which the enzyme typically has separate and independent binding sites where both substrates 
can bind to the enzyme to form a ternary complex. At this point, there have been considerable 
observations made and subsequently confirmed by kinetics analysis to determine that CPR 
proceeds by a sequential random Bi-Bi mechanism (see Figure 6b). 
 
 
 
Figure 6- This is a cartoon of the Ping-Pong mechanism and the Sequential Random Bi-Bi 
mechanism. A and B species represent substrates and P and Q represent products. 
Recreated from M.B. Murataliev et al. (Reference 6) 
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The mechanism of electron transfer in CPR has many unique characteristics which make 
its study quite interesting. The architecture of CPR allows for very close interaction of the flavin 
cofactors and the NADPH coenzyme. This intimacy permits direct electron transfer from NADPH 
to the FAD cofactor and then from the FAD cofactor to the FMN cofactor, without the 
participation of any protein residues [16,25]. The bound NADPH, specifically the nicotinamide 
ring portion, can change from a planar to “boat” configuration which effectively moves the 
hydrogen of the C4 atom close enough to the N5 of the FAD cofactor, about 3.5 Å in distance, 
so that the rapid direct hydride transfer can occur [6,15]. Similarly, the very close and 
“continuous ribbon” orientation of the isoalloxazine rings if FAD and FMN allow for direct 
transfer of electrons between the two flavins. It has been shown that substantial movements of 
the FMN- and FAD-binding domains contribute to bringing the cofactors and substrate in close 
enough orientation for direct transfer. The relative positions of the FAD- and FMN-binding 
domains have been determined to have a large effect on the biological redox properties. 
Several models of domain movement have been suggested. The primary player in domain 
movement is the α-helical “hinge” domain between the FAD-binding domain and the FMN-
binding domain, which allows for the FMN-binding domain to “swing” into and out of position 
to allow electron transfer from the reduced FAD, through the FMN, to the heme of cytochrome 
[10,13,15]. The binding of the NADPH, particularly the adenine portion of the coenzyme, has 
been shown to move the flavins from a distance of 20Å to a mere 4Å, increasing favorability 
upon NADPH binding of intermolecular and intramolecular electron transfer in CPR [15]. The 
NADPH binding represents another domain movement in an overall system which is likely many 
conformational changes in coordination. 
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Another important aspect in the mechanism of electron transfer within CPR is the 
formation of the semiquinone (SQ) of the flavin cofactors, particularly the FMN. Flavin cofactors 
have three redox states: oxidized, semiquinone (one-electron reduced), and hydroquinone 
(two-electron reduced). A unique feature (and application in some biological processes) of the 
flavin cofactor is its ability to participate in both two- and one-electron transfer processes, 
occasionally sequentially as with CPR and other diflavin reductases. The flavin semiquinone 
state can be in the cationic, neutral, or anionic forms, however, in flavoproteins only the 
neutral and anionic forms are found. The neutral and anionic forms of the flavin semiquinones 
are readily distinguished by their electronic absorption properties and are often classified as 
“blue” or “red” for the neutral or anionic semiquinone, respectively (see Figure 7) [17]. The 
major difference between the two is the protonation state of the N5 of the isoalloxazine ring 
(H+ present in neutral form). More specifically, both the CPR flavin cofactors readily and 
exclusively form an “air-stable” blue, neutral radical. This is of interest due to the fact that the 
neutral FMNsq is not usually stabilized and if so only transiently, in most other enzymes except 
for flavodoxins and diflavin reductases [18]. The neutral FMNsq has been shown to be the state 
that transfers the electron to the terminal electron acceptor and this fact demonstrates that 
the reductive cycle of CPR most like proceeds through a 0-2-1-0 mechanism, where the 
numbers represent the number of electrons collectively on both the flavins. The widely 
accepted and holistic turnover mechanism for electron transfer in CPR, and many other diflavin 
reductases, can be seen in Figure 8 and is described as follows: (1) NADPH binds to CPR, (2) 
then NADPH transfers a hydride to the FAD cofactor taking FADox to FADhq (this step is 
theorized to be the rate limiting step), (3) then FADhq transfers a single electron to FMNox 
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taking CPR to the disemiquinoid state with both cofactors in neutral SQ state, (4) FMNsq 
transfers its electron to the terminal electron acceptor taking FMN to the oxidized form 
(binding of the oxidized terminal electron acceptor can occur at any time in steps 1, 2, or 3 and 
most likely binds to CPR after NADPH has bound and transferred electrons), (5) the reduced 
electron acceptor is released from the enzyme and another oxidized electron acceptor binds to 
the enzyme, meanwhile, FADsq transfers its electron to FMNox to take it to FMNsq, (6) 
following this the FMNsq transfers its electron to the oxidized electron receptor to reduce it, 
and finally (7) the second reduced electron receptor is released along with NADP+ [6,18,19]. 
This mechanism demonstrates the central role and importance of the FMN semiquinone 
state in the intermolecular and intramolecular electron transfer process. Because of this, the 
molecular basis for the formation, stabilization, and utilization of this redox state forms the 
fundamental basis and significance of the study described herein and those previously and 
currently addressed in the Swenson laboratory among others.   
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Figure 7- This diagram shows the multiple reduction-oxidation states of the flavin cofactor
 
Figure 8- This figure is a cartoon of the overall electron transfer in CPR (and diflavin reductases 
in general). Ao represents an oxidized electron acceptor and Ar represents a reduced terminal 
electron acceptor. 
Recreated from M.B. Murataliev et al. (Reference 6) 
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Background of Thesis Project: The premise for this thesis project is centered on a few unique 
characteristics of flavodoxin proteins, as they are related to many of the diflavin reductases. 
The first is that flavodoxin proteins, and the homologous FMN-binding domain in CPR and other 
diflavin reductases, are able to stabilize the neutral form of the FMN semiquinone, a radical 
species which is typically only transiently or not at all formed in other enzymes [17,18]. The 
second characteristic of interest is that in many different flavodoxins, the FMN-binding loop has 
been shown to facilitate hydrogen bonding between the backbone carbonyl oxygen of a glycine 
and the N(5)H of the FMN isoalloxazine ring, an interaction that has now been established to 
stabilize this redox state. Additionally, this glycine is conserved in the FMN binding loop of 
many diflavin reductases (see Figure 9), but absent in flavocytochrome P450BM-3; this is 
unique because the FMN semiquinone is not thermodynamically stabilized, but only transiently 
forms the red anionic form. In flavodoxins from Clostridium beijerinckii and Desulfovibrio 
vulgaris, it has been shown that there is a conformational change associated with the reduction 
of the FMN characterized by the “flipping” of the carbonyl group of the conserved glycine 
residue (within the FMN-binding loop) into a position favorable for the glycine-N(5)H hydrogen 
bond formation [20,21].  
To study the importance of this conserved glycine and the conformational change in the 
stabilization of the neutral FMN semiquinone and its role in the overall electron transfer 
process, site-directed mutagenesis was used to replace the conserved Glycine-141 in CPR with 
alanine and threonine. This approach was used based on the results of previous studies of the 
C. beijerinckii and D. vulgaris flavodoxins [20,21]. The conformational energetics of the Gly57-
Asp58 peptide bend in the C. beijerinckii flavodoxin has been shown to correlate with the 
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stability of the reduced states of the FMN cofactor. With oxidized FMN, the Gly57-Asp58 
peptides accept an “O-down” confirmation (with cis isomerization) in which the carbonyl 
oxygen of Gly57 (O57) points away from the flavin.  Thus, there is no apparent hydrogen 
bonding with the N5 of the FMN in this redox state.  As discussed below, this differs from the 
situation in the flavocytochrome P450BM-3 system. However, in the semiquinone and 
hydroquinone states, the Gly57-Asp58 peptide bond adopts a trans “O-up” formation with O57 
pointing towards FMN, forming a strong hydrogen bond with the N(5)H [20]. Evidence for the 
importance of this conformational change and resulting hydrogen bonding interaction was 
indirectly demonstrated by the replacement of  Glycine-57 with four different amino acids with 
differing sidechain properties: alanine (G57A), aspartic acid (G57D), asparagine (G57N) and 
threonine (G57T) [20].The basic premise for those studies was that the unique structural 
propensities of the glycine residue lacking, of course, any sidechain is essential for the 
conformational change and associated interactions.  The presence of any sidechain, even one as 
small as the methyl group of alanine, was expected to interfere with these changes.  Of 
particular interest to this thesis are the G57A and G57T site-directed variants, which served as a 
guide for the corresponding substitutions introduced in CPR. Alanine was introduced as the 
simplest sidechain substitution whereas threonine was utilized to introduce the much more 
conformationally restricting β-branched sidechain. G57A showed almost stoichiometric 
formation of FMNsq (nearly equal to wild-type flavodoxin) with two observable separate 
electron transfer steps. Also similar to wild-type, x-ray crystallography indicated that the O57 of 
the G57A mutant flavodoxin was in cis O-down position with FMNox and trans O-up position for 
the FMNsq and FMNhq states. Contrastingly, G57T showed all three oxidation states of FMN 
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throughout the reduction with only about 52% of stoichiometric FMNsq production. The 
backbone conformation of G57T with FMNox was trans O-down and although with FMNsq and 
FMNhq state the O57 is in the trans O-up position, there were “subtle” changes in geometry of 
the protein/cofactor orientation. In addition, there is evidence to indicate that the energy gap 
between trans O-down and trans O-up in G57T is close to locking the molecule in the O-down 
position [20]. The value of this study was to highlight, for our own project, two amino acids 
which could be substituted for the Glycine-141 in the FMN-binding loop of CPR: alanine with 
potentially minimal effect to kinetics, redox, and conformational changes; and threonine with 
potentially major effect to kinetic, redox, and conformational changes.  Our studies, then, 
would serve two purposes.  First, the introduction of similar amino acid substitutions might 
confirm the generality of the role of a similar conserved glycine residue in CPR, shedding further 
light on a shared function of hydrogen bond formation and associated conformational changes 
to orient the glycine correctly to stabilize and promote the stabilization of the neutral FMNsq.  
Second, unlike for the flavodoxin where electron transfer involves separate and often not well 
known redox partners, similar modifications in CPR will much more effectively allow for the 
detailed study of the influence and role of the formation of the FMNsq on optimal electron 
transport. 
The conserved glycine residue seen in flavodoxins and most diflavin reductases is 
missing from the FMN-binding loop of flavocytochrome P450BM-3 from Bacillus megaterium 
(see Figure 9). The result of this absence is a shorter and less flexible flavin-binding loop. The 
loss of this residue in BM-3 may be the reason for the formation of a hydrogen bond with the 
backbone amide NH group of Asn537 and the N5 of the flavin [22,24]. This change in binding 
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may be responsible for the unique redox and electron transfer properties of BM-3 compared to 
other diflavin reductases, exemplified by the inability of BM-3 to stabilize neutral FMNsq. 
Instead, the anionic form of FMNsq forms, but only transiently during reduction. To address the 
role of the absence of the equivalent glycine in this protein, studies were performed to reinsert 
the glycine residue into equivalent position in the FMN-binding loop (after Tyr536) in both the 
FMN domain and the diflavin reductase portion of BM-3 to determine the overall effect of 
glycine-N(5)H bonding on semiquinone stability and reductase activity. It was found that the 
insertion variant was able to accumulate the neutral form of FMNsq like flavodoxin and CPR, 
although not to the same extent, and based on NMR studies that the Asn537-N5 interaction 
was disrupted in the oxidized state.  The results seem consistent with the newly inserted glycine 
carbonyl forming the hydrogen bond with N(5)H in the reduced state [22]. As a converse to that 
study and as part of the work presented here, the Glycine-141 residue of CPR, was deleted in an 
attempt to make a FMN-binding loop more like that of flavocytochrome P450BM-3. 
Theoretically, this should have significant changes in the amount of neutral FMNsq being 
formed and the mechanism of electron transfer in the Glycine-141 deletion CPR. 
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Figure 9- The amino acid sequence alignment for the binding region flanking the re-face of the 
FMN cofactor for six members of the diflavin reductase family, note the conserved glycine 
residue in red. Flavocytochrome P450BM-3 (P450BM-3), human cytochrome P450 reductase 
(CPR), rat neuronal nitric oxide synthase (nNOS), E. coli sulfite reductase (SR), human 
methionine synthase reductase (MSR) and human novel reductase 1 (NR1). 
Recreated from H.C. Chen and R.P. Swenson (Reference 22). 
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Thesis project objectives: The primary objective of this project, then, is to determine the role of 
the flavin mononucleotide cofactor and, more specifically, the role of the conserved glycine 
residue in the FMN-binding loop in the electron transfer of CPR. To this end, Glycine-141 was 
replaced by amino acids with increasingly large sidechains, i.e. alanine and a β-branched 
threonine.  Additionally, the Glycine-141 residue was deleted, which is thought not only to 
disrupt the N(5)H interaction, but also to reduce flexibility in the FMN-binding loop. The 
primary focus of this project was to obtain significant quantities of the purified Glycine-141 
variants, to characterize them initially, to establish the redox properties of the G141A CPR 
variant, establish their reductase activities relative to wild-type CPR, and to characterize in 
detail the pre-steady-state kinetics associated with both the reductive and oxidative half-
reactions.  By doing so, the role of Glycine-141 in establishing both the redox properties of the 
reductase, as well as, its electron transfer mechanism will have been more thoroughly 
determined.  The overall objectives of this project are, therefore, as follows:  
(1) Transform cells with the G141A CPR containing plasmid.  
(2) Perform cell growths to preferentially express G141A CPR. 
(3) Harvest and purify G141A CPR.  
(4) To analyze flavin content of G141A CPR, with and without FMN incubation, by HPLC analysis 
and compare results to those of WT and G141del CPR. 
(5) Perform a steady-state turnover assay with NADPH and cytochrome c to establish activity of 
G141A CPR and compare this activity to that of WT, G141T, and G141del CPR. 
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(6) Perform a FAD-dependent electron transferase assay with ferricyanide on G141A CPR and 
compare this activity to that of WT, G141T, and G141del CPR. 
(6) Perform an FMN-dependent oxidative titration with sodium dithionite and potassium 
ferricyanide on G141A CPR and compare this activity to that of WT, G141T CPR, and G141del 
FBD. 
 (8) Perform pre-steady state turnover, reductive half-reaction assays on G141A CPR and fit the 
reaction traces. 
 a. Perform in standard conditions  
 b. Perform with varying concentrations of NADP+ to observe competitive binding 
(9) Perform pre-steady state turnover, reductive half-reaction assays on WT CPR and fit the 
reaction traces. 
a. Perform in standard conditions  
 b. Perform with varying concentrations of NADP+ to observe competitive binding 
(10) Perform pre-steady state turnover, reductive half-reaction assays on G141T CPR and fit the 
reaction traces. 
a. Perform in standard conditions  
 b. Perform with varying concentrations of NADP+ to observe competitive binding 
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(11) Perform pre-steady state turnover, reductive half-reaction assays on G141del CPR and fit 
the reaction traces. 
a. Perform in standard conditions  
 b. Perform with varying concentrations of NADP+ to observe competitive binding 
(12) Use reaction trace fittings and kinetics modeling software to model the reductive half-
reaction for WT, G141A, G141T, and G141del CPR. 
 a. With stoichiometric amounts of NADPH 
 b. With NADP+ added to solution 
(13) Perform pre-steady state turnover, oxidative half-reaction assays on G141A CPR and fit the 
reaction traces. 
(14) Perform pre-steady state turnover, oxidative half-reaction assays on Wt CPR and fit the 
reaction traces. 
(15) Perform pre-steady state turnover, oxidative half-reaction assays on G141T CPR and fit the 
reaction traces. 
 (16) Perform pre-steady state turnover, oxidative half-reaction assays on G141del CPR and fit 
the reaction traces.   
(17) Use reaction trace fittings and kinetics modeling software to model the oxidative half-
reaction for WT, G141A, G141T, and G141del CPR. 
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Materials and Methods 
Materials: The QuikChange® Site-Directed Mutagenesis Kit was purchased from Stratagene.  
Escherichia coli stain DH5α Max Efficiency competent cells were obtained from Invitrogen and 
BL21 (DE3) Rosetta strain cells were purchased from Novagen. Sodium dithionite was 
purchased from JT Baker. Ampicillin was purchased from Amresco. Chloramphenicol, horse 
heart cytochrome c, NADPH, NADP+, FMN, FAD, and potassium ferricyanide were all purchased 
from Sigma. All other chemicals used were analytical reagent grade. 
Mutagenesis, transformation, and expression of G141A CPR: Three CPR variants were generated 
for studied in this thesis. Included those in which Glycine-141 was replace by threonine (G141T 
CPR), by alanine (G141A CPR), and in which this residue was deleted (G141del CPR).   The 
primary focus of my thesis research was initially on the mutagenesis, expression, purification, 
and characterization of the G141A CPR variant. The G141T CPR variant was generated, 
expressed, purified, and characterized by Matthew Wohlever. The G141del CPR mutant was 
generated, expressed, and purified by Amanda McKenna, while the same deletion was 
introduced in the isolated recombinant FMN-binding domain of CPR by Yicheng Long.  
The G141A variant was generated in soluble form (lacking the N-terminal membrane 
anchor region) of recombinant rat cytochrome P450 reductase using the QuikChange® site-
directed mutagenesis protocol. The complementary oligonucleotides used for generating the 
glycine to alanine substitution were (with the altered nucleotides underlined), 
5’-GCCACATACGCAGAGGGCGACC-3’ and 5’-GGTCGCCCTCTGCGTATGTGGC-3’. 
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The open reading frame obtained from a cDNA clone for soluble rat CPR previously prepared 
and recloned in the T7-7 expression plasmid (Stratagene) was used as the template for 
mutagenesis.  The altered plasmid preparation obtained from the QuikChange procedure was 
used to transform competent E. coli strain DH5α Max Efficiency cells.  Several colonies from 
cells grown on LB agar plates containing ampicillin for selection were selected, cultured 
separately, and the pT7-7/G141A CPR plasmids purified via Qiaprep® Spin columns using 
prescribed protocol. The plasmid DNA was sequenced by the Plant Microbe Genomics Facility at 
the Ohio State University to confirm the site-specific mutations as well as to insure the integrity 
of the entire coding region. A positive confirmed G141A CPR mutant plasmid was then used to 
transform the BL21 (DE3) Rosetta E. coli strain which was cultured in LB media containing 
ampicillin (100 μg/ml) and chloramphenicol (35 μg/ml). The Rosetta strain was required for the 
expression of this eukaryotic protein in E. coli cells to improve yields due to the codon usage 
differences.  Expression of G141A CPR was induced by IPTG, in methods described by Chen and 
Swenson [24]. 
Purification of G141A CPR: The E. coli cells were harvested by centrifugation and the pellets 
were resuspended in 50 mM Tris, pH 7.7 buffer containing 0.1 mM EDTA, 0.05 mM 
dithiothreitol and 10% glycerol (designated as “Buffer A”). Cells were lysed using a French press 
cell at an effective cell pressure of 12,000 psi followed by centrifugation to remove cellular 
debris.   G141A CPR was purified from the cell extracts by affinity chromatography on agarose 
resin contained covalently bound 2’,5’-ADP (Sigma Chemicals) by the procedure described by 
Rock et al. [26], except using a slightly different buffer compositions.  The 2’,5’-ADP represents 
an analog for NADP+, one of the products of CPR.  Cell lysates were loaded onto the column and 
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washed with Buffer A.  G141A CPR was eluted with Buffer A containing 20 mM 2’(3’)-AMP and 
100 mM NaCl. Fractions were collected during elution and flavin content was monitored using 
an Agilent Model 8453 photodiode array spectrophotometer.  Fractions containing a typical 
flavin absorbance spectrum associated with CPR and with A274:A450nm ratios less than 10 
were pooled and concentrated using Amicon® 10kDa NMWL Ultra Centrifugal Filter Devices 
(Centricon-10).   Three rounds of solvent exchange with Buffer A using the Centricon-10 
ultrafiltration device was performed to remove the 2’(3’)-AMP and NaCl prior to storage at  -
80°C.  Purity of the G141A CPR preparations was established by standard SDS polyacrylamide 
gel electrophoresis methods.  Purity estimated to exceed 95% was routinely achieved.   
Flavin content analysis of CPR variants: The flavin cofactor content (FAD and FMN) of the CPR 
variants was determined by high performance liquid chromatography (HPLC) using a LKB 
Bromma 2150-2152 HPLC system and a procedure similar to Marohnic et al. [29], with the 
exceptions that 450 nm was the observed wavelength and flavin standards were at 40 μM for 
FAD and 60 μM for FMN. In addition, for the variants a number of trials were done to examine 
the FMN reconstitution. In these experiments, the enzyme was incubated in 5-fold excess of 
added FMN in the dark at 4°C for one hour.  
Spectral analyses and steady-state turnover (SSTO) assay of CPR: All ultraviolet-visible 
absorbance spectra were recorded on Agilent Model 8453 photodiode array 
spectrophotometer at 25°C. The cytochrome c reductase activity of CPR was measured under 
saturating substrate concentrations with NADPH used as the electron donor essentially as 
described by Shen et al. and Klein and Fulco [16,27]. Assay solutions contained 270 mM 
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potassium phosphate buffer, pH 7.7, 100 μM NADPH, 65 μM cytochrome c, and CPR 
concentrations of 0, 2.5, 5.0, 7.5, and 10 nM. Cytochrome c reduction was monitored at 550nm 
with Δε = 21 mM-1cm-1.  
FAD-dependent electron transferase assay with ferricyanide: Ferricyanide reductase activity of 
CPR was performed under steady-state turnover conditions in 270 mM potassium phosphate 
buffer, pH 7.7 containing 100 μM NADPH, 500 μM potassium ferricyanide, and CPR 
concentrations of 0, 2.5, 5.0, 7.5, and 10 nM. Ferricyanide reduction was measured at 420 nm 
with Δε = 1.04 mM-1cm-1 [28]. 
Anaerobic reductive and oxidative titrations: Anaerobic reductive and oxidative titrations of the 
CPR variants were performed using sodium dithionite and potassium ferricyanide, respectively, 
in 270 mM potassium phosphate buffer, pH 7.7. Sodium dithionite and potassium ferricyanide 
solutions were made anaerobic by bubbling extensively with purified argon. CPR samples, 
typically 1.0 mL at 20 μM, were placed in a specially designed sealable titration cuvette and 
made anaerobic by completing several alternating gas exchange cycles with argon and a partial 
vacuum (water aspirator).   Reductive titrations were performed by adding substoichiometric 
amounts (typically in 1 μL volumes) of anaerobic sodium dithionite using a special gas-tight 
Hamilton syringe assembly attached to the cuvette.  Oxidative titrations were performed by 
first reducing the CPR sample with a slight excess of sodium dithionite followed by the addition 
of substoichiometric amounts of anaerobic potassium ferricyanide as described above.  After 
each aliquot of titrant was added, the sample was gently but thoroughly mixed, and allowed to 
achieve equilibrium by monitoring the spectral changes until no further changes were 
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observed.  A final spectrum between 300 and 700 nm was obtained and saved before the next 
addition of the titrant.   For these experiments, oxidized flavin was measured at 455 nm and 
formation of the flavin semiquinone was measured at 580 nm. Both the reductive and oxidative 
titration procedures were used to titrate the WT, G141T, and G141del variants of CPR, however 
the results of these two reaction types are very comparable.  The oxidative protocol was used 
for the G141A variant. 
Pre-steady state kinetic analyses:  Both the oxidative and reductive half-reactions for each CPR 
variant were performed on a Hi-Tech Scientific SF-61 stopped flow spectrophotometer which 
mixes equal volumes of two reactants with a mixing time (or sometimes referred to as the 
“dead time”) of approximately 1.5 msec. After mixing, the flow is abruptly stopped and the 
absorbance changes at a specified wavelength are recorded and plotted as a function of time 
by the instrument software.  For the reductive half-reaction, a 40 μM solution of CPR in 50 mM 
potassium phosphate, pH 7.0 in one syringe was mixed with 40, 200, or 400 μM NADPH in the 
same buffer in the second driving syringe (all concentration are reported as the pre-mixing 
concentration). All solutions were made anaerobic by extensive bubbling with argon except for 
the CPR solution for which only the buffer was sparged with argon before a small volume of a 
concentrated stock of the CPR variant was added (to avoid surface denaturation). These 
conditions represent the basic reductive half-reactions, however, competitive binding 
experiments were also performed in which 0, 40, 80, 200 or 400 μM NADP+ was added to the 
solutions containing the NADPH (again at 40-400 μM).   Reduction was monitored at 450 nm to 
record the loss of the oxidized flavin and at 590 nm to observe the formation of the flavin in the 
semiquinone state. 
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 Similarly, the oxidative half-reaction of CPR was determined in 100 mM potassium 
phosphate, pH 7.0, again with all solutions made anaerobic by extensive argon bubbling. For 
these experiments, 10 μM CPR was mixed with solutions containing 10 μM NADPH and 10, 20, 
40, 80 or 160 μM cytochrome c.  It was assumed (and established separately) that the NADPH 
would very rapidly reduce the CPR prior to its transferring electrons to the cytochrome.  This 
greatly simplified the experiment in that the CPR need not be retained in the reduced state for 
extensive periods of time, which is often difficult to achieve.  The reduction of cytochrome c 
was measured at 550 nm. 
Kinetics modeling of reductive and oxidative half-reactions: Data from the oxidative and  
 
reductive half-reactions were analyzed using KinTek® Global KinTek Explorer software. 
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Results and Discussion 
Purification of G141A CPR: Over-expression of the soluble recombinant form of G141A CPR was 
achieved through the induction by IPTG of the BL21 (DE3) Rosetta strain of E. coli transformed 
with the pT7-7/G141A CPR plasmid.  The expressed holoprotein was purified from the cell 
extracts using affinity chromatography based on the NADP+ analog, 2’, 5’-ADP as evidenced by 
the elution of yellow-colored protein fractions by the soluble competing ligand 2’(3’)-AMP. To 
determine the purity of the G141A CPR protein obtained from the column, SDS-PAGE was 
performed. The samples represented on the gel are the combined fractions eluded from the 
affinity column, which showed considerable flavin content. The results of the SDS-PAGE gel 
demonstrated that the protein obtained was >99% pure (see Figure 10). This level of purity of 
G141A CPR clearly demonstrates the efficiency of this one-step affinity chromatographic 
procedure and was certainly sufficient to use for analytical experiments with no further 
purification steps being required.  
Analysis of the flavin content of G141A, G141del, and WT CPR variants: High performance liquid 
chromatography (HPLC) analyses were performed to determine the flavin content of each CPR 
variety. Previously, it had been shown in flavocytochrome P450BM-3 that some alterations to 
the FMN binding loop can actually prevent or weaken the binding of the FMN cofactor [22]. 
This is of concern due to the fact that lack of a FMN cofactor can inhibit electron transport in 
CPR, resulting in non-functional enzymes.  
 Reverse phase HPLC analyses was performed as described in “Materials and Methods”.  
Separation and retention times were established by injecting 2.0 nmol standards of FAD and  
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Figure 10- This is a photograph of the SDS-PAGE gel of purified G141A CPR. Lane 1 has the 
Benchmark® Protein Ladder (Invitrogen). Lane 2 has 10 μL of the G141A CPR stock solution 
added. Lane has 15 μL of the G141A CPR stock solution added.  
 
 
 
 
 
 
 
3 2 1 
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FMN prior to the analysis of the experimental samples.  Flavin elution was monitored at 450 nm 
and the relative peak height (or peak areas) was established for that amount of flavin cofactor. 
(Note that standard curves over the concentration range used in this study had been previously 
established in this laboratory.)  Comparing peak heights/areas of the CPR samples to the 
standards allowed for approximation of flavin content. Experimental samples were prepared as 
followed.  Aliquots containing 2.0 nmol of G141A CPR or other CPR variants were boiled for ten 
minutes to denature the protein and release flavin cofactors.  The boiled samples were cooled 
and centrifuged to remove any denatured protein precipitate that might have formed.  An 
exact volume of the clarified supernated CPR was injected onto the HPLC column and 
chromatography performed.  Two peaks were observed that corresponded to the retention 
times for the FAD and FMN standards.  Quantitation by peak height showed that 1.89 nmol of 
FAD were present in the sample, but only 0.855 nmol of FMN was present, with a FMN:FAD 
ratio of 0.45 (see Figure 11a). This was interpreted to mean that only 45% of CPR in the sample 
was fully constituted with both cofactors. This experiment was repeated for WT CPR and the 
results showed a FMN: FAD ratio of 0.93 or 93% of FMN retention. From these results, it was 
fairly clear that the substituted alanine residue caused enough biochemical changes to effect 
the binding of the FMN, but as expected the FAD cofactor, bound to a separate domain, is 
unaffected by the Glycine-141 alteration. So, either during the normal growth and expression 
conditions G141A CPR does not assume a structure for the FMN-binding domain that can 
efficiently acquire stoichiometric amounts of the FMN cofactor or during the purification 
process of G141A CPR FMN cofactor is lost. In an effort to resolve this issue, a study was 
conducted to attempt to reconstitute the purified G141A CPR with exogenously added FMN 
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cofactor.  For these studies, the enzyme was incubated in 5-fold excess added free FMN 
followed by a solvent exchange to remove non-bound FMN, and HPLC analysis was repeated. 
This treatment resulted in a FMN: FAD ratio of 0.82 (see Figure 11b), representing an 
improvement in the level of bound FMN cofactor.  These results suggest that the lower 
FMN:FAD ratio in untreated G141A CPR is likely the result of the loss during purification of a 
somewhat more weakly bound FMN cofactor in this variant.  The fact that the enzyme can be 
significantly reconstituted further suggests that the FMN domain is folding properly during 
expression.  The effectiveness of the FMN incubation in reconstituting enzyme led to a change 
in lab protocol so that all CPR variants, prior to kinetic or redox analysis, are first incubated in 
excess FMN. G141del CPR was also analyzed by HPLC after a FMN incubation to determine a 
FMN: FAD ratio of 0.69, which is less than G141A or WT CPR. This result which could be 
expected considering the shorter less flexible FMN-binding loop appears more like BMR (the 
reductase portion of flavocytochrome P450BM-3) and the recombinant BMR has FMN:FAD 
ratios of between 0.56-0.65 showing a relatively low FMN retention compared to WT CPR 
[unpublished HPLC results from the Swenson lab].  
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Figure 11a- This chart represents the HPLC flavin analysis results of G141A CPR at 450nm 
without free FMN incubation. The ratio of FMN:FAD was 0.45 showing only 45% of FMN 
retention in the protein 
 
 
Figure 11b- This chart represents the HPLC flavin analysis results of G141A CPR at 450nm with 
5-fold excess free FMN incubation. The ratio of FMN:FAD was 0.82 showing only 82% of FMN 
retention in the protein. 
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Steady-state turnover assay of G141A CPR with NADPH and Cytochrome c:  The purified G141A 
CPR was characterized by the evaluation of its steady-state turnover (SSTO) activity using 
NADPH as the physiological electron donor and cytochrome c as the terminal electron acceptor.  
It is important to note that although cytochrome c is not the true redox partner for CPR, this 
cytochrome is routinely used and widely accepted as a good measure of cytochrome reductase 
activity because of the stability of the reduced form and the ease of use experimentally [16,27]. 
Generally speaking, this experiment will observe the movement of electrons from the bound 
NADPH reductant to the FAD cofactor then the FMN cofactor and finally to the cytochrome c 
acceptor. This reduction of cytochrome c is measured at 550 nm and as stated the Δε = 21 mM-
1cm-1 (this value represents the difference in absorbance between oxidized cytochrome c with 
Δε = 8.9 mM-1cm-1 and reduced cytochrome c with Δε = 29.9 mM-1cm-1). Five different trials of 
this reaction were performed, which differed in the concentration of G141A CPR in the reaction 
cuvette. The assay buffer was always 270 mM potassium phosphate, pH 7.7 and in each trial 
the NADPH and cytochrome c concentrations were 100 μM and 65 μM, respectively. The 
concentration of G141A CPR was varied between trials and was 0, 2.5, 5.0, 7.5, or 10 nM in the 
reaction cuvette, but the assay at each CPR concentration was performed in triplicate. For these 
SSTO assays, the reactants, NADPH and cytochrome c, are in fairly high excess compared to 
CPR.   However, because both are consumed during the assay, the initial reaction velocity of 
cytochrome c reduction is measured for only the first 180 seconds of reaction. These initial 
velocities (ΔAU/s) are converted to nmol/min of cytochrome c reduced which is compared to 
the nmol of CPR in the reaction cuvette to determine the overall turnover number in 
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nmol/min/nmol (min-1). This number was determined graphically by linearly comparing the 
turnover number at each concentration of G141A CPR and fitting the data (see Figure 12). 
 The cytochrome c reductase activity of G141A CPR was measured for two primary 
reasons: (1) if the protein was folded incorrectly, lost the ability to bind a flavin cofactor, and/or 
was inactive for some other reason; these problems would result in serious effects on 
functional activity and (2) the turnover number for WT CPR (obtained from literature and 
experimentally by M. Wohlever), G141T (experimentally obtained by M. Wohlever), and 
G141del CPR (experimentally obtained by A. McKenna) had been established (see Figure 13); 
allowing for easy comparison of relative activities. It was determined that our expressed and 
purified G141A CPR was functional with a turnover number of 4600 ± 450 min-1 (see Figure 12). 
Additionally, we have shown that the turnover number for G141A CPR is 118% of that rate of 
WT CPR, determined to be 3900 min-1. This result was a bit unexpected, but student t-tests 
showed that the increased activity for G141A, compared to WT, was not statistically significant. 
The other CPR with substitutions for the Glycine-141 residue only had 72% (G141T = 2800min-1) 
and 44% (G141del = 1700 min-1) the activity of WT CPR (see Figure 13 for the data table). It was 
assumed that the activity of the G141A CPR variety would also be less than that of WT CPR 
considering the methyl side-chain would have some effect on the conformational change of the 
FMN-binding loop and consequently on the stability of the FMNsq. However, as previously 
noted, experiments in which the conserved glycine in the flavodoxin of C. beijerinckii was 
substituted for alanine showed very little effect to overall redox, activity, and structural 
properties of the protein [20].  
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Figure 12- This is the graphical analysis and linear fit of the cytochrome c reductase activity of 
G141A CPR. Fitting the triplicate trials of this SSTO experiment at each of the different G141A 
CPR concentrations gives slope, which represents a specific activity of 4638.7 nmol/min/nmol; 
which with calculated error is represented as 4600 ± 450 min-1. 
 
 
Cytochrome c reductase activity of CPR varieties   
Protein Sample Turnover Number (nmol/min/nmol) Percent Activity of Wild-Type 
WT CPR (lit.) 3900 -- 
WT CPR 3900 ± 100 100% 
G141A CPR 4600 ± 4501 118% 
G141T CPR 2800 ± 3002 72% 
G141del CPR 1700 ± 4203 44% 
 
Student t-test:  1 p = 0.058 (not statistically different from WT); 2 p = 0.0038; and 3 p = 0.0009. 
Figure 13- This figure represents the experimentally obtained values of cytochrome c 
dependent SSTO activity of a number of CPR varieties. 
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FAD-dependent electron transferase assay with ferricyanide: The cytochrome c reductase assay 
measures the entire electron transport process from NADPH to the cytochrome c proceeding 
through both the FAD and FMN cofactors. However, utilizing a potassium ferricyanide 
reductase assay allows for the measurement of the transfer of electrons from NADPH to the 
FAD cofactor and finally to a ferricyanide molecule [16]. This electron transfer activity 
functionally removes the participation of the FMN cofactor and more directly monitors CPR’s 
ability to accept the electrons from the hydride transfer of NADPH. Like the cytochrome c 
reductase assay, ferricyanide activity assays were performed in SSTO conditions with excess 
reactants. The concentrations of NADPH and ferricyanide were 100 μM and 500 μM in the 
reaction cuvette, respectively. The concentration of G141A CPR was varied between 
experimental trials and was 0, 2.5, 5.0, 7.5, or 10 nM.  The assay was performed in triplicate at 
each CPR concentration.  This assay measures enzyme activity by observing the initial rate of 
decrease of absorbance at 420 nm, which represents loss of oxidized ferricyanide (Δε = 1.04 
mM-1cm-1). These initial rates (ΔAU/s) are converted to nmol/min of ferricyanide reduced which 
again is compared to the nmol of CPR in the reaction cuvette to determine the overall turnover 
number to be 5700 ± 500 min-1 (nmol/min/nmol). This number was determined graphically by 
linearly comparing the turnover number at each concentration of G141A CPR and fitting the 
data by linear regression analysis (see Figure 14). The SSTO value for the ferricyanide reductase 
activity for WT, G141T and G141del CPR have been determined under similar conditions which 
allows for comparison with G141A CPR data (each CPR variant’s specific activity obtained by the  
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Figure 14- This is the graphical analysis and linear fit of the ferricyanide reductase activity of 
G141A CPR. Fitting the triplicate trials of this SSTO experiment at each of the different G141A 
CPR concentrations gives slope, which represents specific activity, of 5753.4 nmol/min/nmol; 
which with calculated error is represented as 5700 ± 500 min-1. 
 
Ferricyanide FAD dependent reductase activity of CPR varieties 
Protein Sample Turnover Number (nmol/min/nmol) Percent Activity of Wild-Type 
WT CPR (lit.) 7800 -- 
WT CPR 6600 ± 700 100% 
G141A CPR 5700 ± 5001 86% 
G141T CPR 4000 ± 8002 61% 
G141del CPR 4100 ± 2403 62% 
 
Student t-test:  1 p = 0.144 (not statistically different from WT); 2 p = 0.0133; and 3 p = 0.0043  
Figure 15- This figure represents the experimentally obtained values of ferricyanide (FAD) 
dependent SSTO activity of a number of CPR varieties. 
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same experimenter as cytochrome c reductase values). The results show that all Glycine-141 
mutant variants have lower activities than WT CPR.  Compared to WT CPR, G141A has 86% 
activity (which by student t-test was shown not to be statistically different from WT CPR), 
G141T has 61% activity, and G141del CPR has 62% activity (see Figure 15). The changes in 
ferricyanide reductase activity do seem to have a correspondence to the size of the Glycine-141 
alteration. The minimal sidechain of alanine has a smaller effect than the  -branched threonine 
or the residue deletion. These findings are interesting considering the target of this assay is the 
FAD-binding domain, which is identical for WT, G141A, G141T, and G141del CPR. Therefore, it 
was expected that ferricyanide reductase activity between the variants should be very similar, 
but it was not.  This phenomenon has been observed previously in our lab.  While the cause is 
not know with any certainty, a possible explanation may be related to the idea that in the CPR 
enzyme there is a substantial amount of domain-domain interaction and movement 
accompanying each step of the electron transfer process [6,10,13,15].  It seems plausible that 
the alterations to the Glycine-141 residue and the changed redox properties of the FMN 
cofactor and binding domain could be having an effect on the properties of the FAD-binding 
domain through changes in these interactions.  Thus, our variants may, for the first time, be 
suggesting a role of the FMN domain in the regulation of electron transfer to and from the FAD, 
which is seemingly contrary to the basic premise offered in the literature.  The observation that 
ferricyanide, with NADPH present, could be reduced by the FAD domain was based on the 
retention of this activity in CPR in which the FMN cofactor has been removed and by 
recombinant forms of the isolated FAD-binding domain alone [15, unpublished work from this 
laboratory].  Further research will be necessary to clarify this issue, however. 
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Anaerobic oxidative titration of G141A CPR with ferricyanide:  The sequential spectrochemical 
titration of flavoproteins with substoichiometric amounts of chemical reductants or oxidants 
under anaerobic conditions is a well established means of establishing the formation, identity, 
and relative thermodynamic stabilization of the know redox states of the bound flavin 
cofactors.  Each redox state has a distinct UV-visible absorbance spectrum which can be 
effectively monitored during the titration.  Typically the reductive and oxidative processes are 
equivalent and freely reversible thermodynamically in the reductases and related flavoproteins.  
Furthermore, the accumulation of nearly stoichiometric levels of the “blue” neutral 
semiquinone state for both the FAD and the FMN cofactors, the so called “disemiquinoid state” 
is a distinctive “hallmark” feature of WT CPR *6, 28, 30+. Thus, the anaerobic oxidative titration 
of G141A CPR was performed to evaluate the relative stability of each of the redox states of the 
flavin cofactors in this variant.  Because the focus of this study was on the role of Glycine-141 in 
the stabilization of the one-electron reduced state of the FMN cofactor, emphasis was placed 
on monitoring the formation and stability of the “blue” neutral semiquinone as it is formed as 
G141A CPR is being oxidized.  Similar titrations have performed in both the reductive and 
oxidative directions for WT CPR, G141T CPR, and G141del FBD; so the relative amounts of 
semiquinone formed can be easily compared [30]. It should be noted that the reductive 
titration was attempted for the G141A CPR variant, but was not successful due to the difficulty 
in removing all traces of molecular oxygen from the protein solution.  However, because of the 
reversibility of the process, similar results can (and have for the other variants) be obtained by 
first reducing the G141A CPR with sodium dithionite (which also destroys any residual oxygen in 
the solution) followed by the step-wise re-oxidation of the reductase with the addition of  
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Figure 16- This series of spectrum shows the gradual anaerobic oxidation of G141A CPR. The 20 
μM sample of G141A CPR was first fully reduced by 2.0 mM sodium dithionite and then 
oxidized stepwise by 1.0 μL additions of 0.5 mM potassium ferricyanide. Each different colored 
line represents the system at equilibrium after oxidant addition. Arrows at 580 nm show the 
formation and subsequent loss of the semiquinone species. The arrow at 455 nm shows the 
gradual gain of oxidized flavin. 
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small volumes (1 μL) of an anaerobic potassium ferricyanide solution. Once the system reached 
equilibrium after ferricyanide addition, as indicated by stable UV-visible absorbance spectra, a 
full spectrum of the reaction cuvette was recorded (see Figure 16).  The observed changes in 
absorbance at 455 nm and 580 nm represents the formation of oxidized and semiquinone 
flavin, respectively. From the spectral path, the order of events can be seen: (1) as electron 
equivalents are removed from the G141A CPR system there is an initial increase in absorbance 
at 580 nm indicating the formation of the “blue” neutral semiquinone radical, (2) then as 
greater than two electron equivalents are removed you begin to see a loss of absorbance at 580 
nm and, simultaneously, a gain of absorbance at 455 nm illustrating the presence of fully 
oxidized flavin, and (3) finally there is complete loss of absorbance at 580 nm when absorbance 
at 455 nm reaches its highest value.  
 The results for this experiment become pertinent when the amount of semiquinone 
formed by G141A CPR is directly compared to the amount of semiquinone formed with WT 
CPR. A similar anaerobic reductive titration was performed with WT CPR [30] which was 
observed to form about 90% of the disemiquinoid species expected when comparing 
experimental absorbance change at 580 nm absorbance to the calculated absorbance change 
based on the molar extinction coefficient of FMNsq and FADsq at 580 nm.  The spectral changes 
occurring during the titrations for the G141A and WT CPR enzymes were compared by aligning 
traces on a 455 nm vs. 580 nm chart for both reactions (see Figure 17). The result shows that 
G141A CPR forms only about 80% of the semiquinone that WT CPR does. Because CPR contains 
two flavin cofactors, FAD and FMN, both of which are capable of forming the neutral 
semiquinone state, it is not possible with absolute certainty to know which flavin is displaying a  
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Figure 17- This 455 nm vs. 580 nm plot compares the anaerobic oxidative titration of G141A 
CPR with the anaerobic reductive titration of WT CPR. Specifically this plot is useful in 
comparing the formation of flavin SQ (580 nm) as it compared to the total oxidation of flavin 
(455 nm). The double headed arrow shows the disparity of semiquinone formation between 
WT and G141A CPR. Values for G141A CPR were normalized to WT CPR due to differences in 
initial protein concentration. WT CPR data calculated from reference 30. 
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lesser semiquinone stability.  However, it is very reasonable to assume that since the only 
distinction between these two enzymes is the alteration in the FMN-binding loop and that a 
similar alteration in the flavodoxin homolog also disrupts the FMN radical, the difference in 
accumulation of the neutral semiquinone is associated with the destabilization of the FMN 
semiquinone state in response to the G141A residue substitution.  
To further make a case, the G141A CPR oxidative titration has been compared with the 
reductive titration of the G141T CPR variant [performed by M.Wohlever]. G141T CPR 
accumulated even less semiquinone than G141A CPR and compared to WT CPR, there is only 
about 73% semiquinone formation in G141T relative to WT (see Figure 18). Anaerobic reductive 
experiments with sodium dithionite have also been performed on the purified isolated 
recombinant G141T FMN-binding domain itself (designated FBD). These results showed that 
compared to WT FBD, G141T stabilized the formation of only about 30% the neutral FMNsq. 
This gives support to the conclusion that the loss of absorbance at 580nm seen in G141T and 
G141A CPR assays corresponds to the destabilization of the FMNsq, not the FADsq.  These 
results are also consistent with similar modifications within the bacterial flavodoxin (the model 
for my studies) which only contains the single FMN cofactor [20].  Finally, similar preliminary 
experiments have been conducted with the G141del FBD and the results from this showed 
virtually no (<10%) formation of the FMNsq compared to WT FBD. Collectively, these 
experiments demonstrate in the FMN-binding domain of CPR that the nature of the Glycine-141 
alterations, like those seen in the C. beijerinckii flavodoxin experiments [20], can result in the 
disruption of FMN-binding loop and its conformation changes which affect the hydrogen 
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bonding with the N(5)H of FMNsq and its stability. The consequences of this disruption on the 
electron transferring activity of CPR were addressed next. 
 
 
Figure 18- This 450 nm vs. 580 nm plot compares the anaerobic reductive titration of G141T 
CPR with the anaerobic reductive titration of WT CPR. Specifically this plot is useful in 
comparing the formation of flavin semiquinone (580 nm) as it compared to the total oxidation 
of flavin (455 nm). The double headed arrow shows the disparity of SQ formation between WT 
and G141T CPR. Values for G141T CPR were normalized to WT CPR due to differences in initial 
protein concentration. WT CPR data calculated from reference 30. 
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Reductive half-reaction of WT, G141A, G141T and G141del CPR: The anaerobic reductive and 
oxidative titrations demonstrated that the stability of the FMNsq is directly related to the 
disruption caused by the size and structure of the sidechain substitutions introduced for 
Glycine-141 or its total deletion; meaning that alanine introduced the smallest change at the 
position of the glycine residue and resulted in the smallest alteration in FMNsq stabilization, 
whereas the more drastic deletion of the glycine residue itself caused the largest change in the 
accumulation of the FMNsq. Similarly, cytochrome c reductase assays demonstrated that there 
were differences in rate of steady-state turnover activity between WT, G141T and G141del CPR 
variants but less so for G141A. However, there are many mechanistic steps associated with the 
overall reductase activity.  Any one or a combination of several may represent the rate-limiting 
step(s) in this process.  Furthermore, it was somewhat surprising given the generally accepted 
role of the FMNsq state in cytochrome reduction that its loss of stability and lack of 
accumulation in the G141del variant did not affect cytochrome reduction in a more substantial 
manner.  Why is this?  Thus, the next step in this project was to examine how and to what 
extent the loss of stability of the FMNsq caused by the Glycine-141 alterations specifically 
affects the electron transfer in the mutant CPR variants. To do this, pre-steady state turnover 
assays were performed using a Hi-Tech Scientific SF-61 stopped-flow spectrophotometer. This 
instrument allows for a reaction to be monitored within the first 1.5 milliseconds of mixing two 
solutions and is therefore a valuable tool in characterizing the rapidly occurring electron-
transfer reactions of CPR. Additionally, the use of pre-steady state kinetics allowed us to dissect 
the overall electron transfer performed by CPR into two smaller reactions: (1) the reductive 
half-reaction (RHR) that consist of electrons moving from NADPH to CPR and between the flavin 
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cofactors and (2) the oxidative half-reaction (OHR) that consist of electron moving from their 
respective cofactors in CPR to cytochrome c as the terminal electron acceptor.  
 As was previously stated, the RHR observes the transfer of electrons from a bound 
NADPH to CPR through the following proposed mechanism shown in Figure 19. The first step is 
the binding of NADPH, which is assumed to be very fast even at stoichiometric levels (and 
subsequently confirmed by the kinetic data). Secondly, NADPH transfers a hydride to the FAD of 
CPR, which will be shown to be the rate limiting step. Finally, and also very quickly, the FADhq 
transfers a single electron to FMNox forming the disemiquinoid (FADsq and FMNsq) form of 
CPR. Therefore, this simple mechanism should result in spectrophotometric changes that occur 
as a single exponential phases involving the loss of absorbance at 450 nm and a gain of 
absorbance at 590 nm, reflecting the loss of oxidized flavin and the formation of the 
disemiquinoid state.  Both these absorbance changes should occur at the rate of hydride 
transfer if this step is truly rate limiting.  This is the model shown in Figure 19. 
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Figure 19- This is a cartoon of two electron reduction of CPR. Note the rate limiting hydride 
transfer step. 
 
 
Reductive half-reaction of WT CPR: The first set of experiments performed involved observing 
the course of the RHR of all CPR variants as a function of the concentration of the NADPH 
concentration. For these experiments, the concentration of CPR was 40 μM for all trials and the 
concentration of NADPH was 40, 200, or 400 μM. (Note:  Throughout these sections describing 
the stopped-flow experiments, the reported concentrations of the reactants are those before 
mixing.   The final concentrations within the stopped-flow spectrophotometer observation cell 
will be half the concentration listed due to solution mixing in the reaction chamber of the 
instrument.) For each different concentration of NADPH, the experiment was performed in 
triplicate and the reactions observed at either 450 nm or 590 nm. The triplicate reaction traces 
were then combined into average reaction traces. For fitting and comparison, the 450 nm and 
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590 nm data was normalized to begin at zero and were plotted together (see Figure 20a-c). As 
can be seen, the RHR reaction traces for 40, 200, and 400 μM NADPH were not a single phase of 
reduction as might have been anticipated for the simple reductive mechanism outlined above. 
Furthermore, the initial loss of absorbance at 450nm (reduction of the FAD) corresponded with 
the increase in absorbance at 590nm (the formation of the disemiquinoid state).  This 
observation is consistent with the reduction of the FAD being the rate limiting step with the 
formation of the disemiquinoid state then subsequently occurring at a faster rate.  However, 
again, this mechanism does not predict the bi- or triphasic kinetic characteristics observed on 
these conditions. What is the cause?  The appearance of a biphasic reduction of WT CPR was 
not entirely unexpected as Shen et al. showed that the RHR can proceed through two phases 
with excess NADPH added, when measuring change in absorbance at 452 nm and 585 nm 
[16,19]. However, at this point our identification of multiple phases was based on cursory 
inspection of the traces, therefore, to specifically identify and determine values for these rates 
the data was transferred into the SigmaPlot graphical plotting program for iterative fitting. 
Global fits of the 450 nm and the 590 nm data were performed on the averages traces for the 
40, 200, and 400 μM NADPH trials. Initially, a single and then a double exponential equation 
were used to fit the data (exponential fits have been used to fit CPR RHRs both in this lab and in 
the literature [19]), but satisfactory fits were only achieved when using a triple exponential, 7 
parameter fit (see Equation 3, 4, and 5). 
(3) y = y0 + ae
-bx + ce-dx + ge-hx        (this is the generic SigmaPlot equation) 
(4) A450 = y0+ A1
-kobs1t + A2
-kobs2t + A3
-kobs3t 
(5) A590 = y0 + A1
-kobs1t + A2
-kobs2t + A3
-kobs3t 
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In equations 4 and 5, y0 represents final absorbance; A1, A2, and A3 represent relative amplitude 
values; and kobs1, kobs2, and kobs3 represent the observed rate constants (referred to as K1, K2 and 
K3 in this thesis). All of these values can be seen in the table in Figure 20d.  
 The presence of a triphasic reduction was unseen in previous reductive half-reactive 
studies of CPR [16,19], so the third phase could not really be compared, but the first two rates 
could be compared to literature values. Gutierrez et al. showed that, under identical buffer 
conditions, the RHR of human CPR was biphasic and at stoichiometric NADPH had values of K1 = 
20 s-1 and K2 = 3.0 s-1 [13] and at 20-fold molar excess NADPH had values of K1 = 20 s-1 and K2 = 
3.5 s-1 [19]. Our experimental WT CPR at stoichiometric NADPH had values of K1 = 42.6 s-1 and 
K2 = 5.72 s-1, at 5-fold molar excess NADPH had values of K1 = 30.6 s-1 and K2 = 7.62s-1, and at 
10-fold molar excess NADPH had values of K1 = 27.5 s-1 and K2 = 6.0 s-1. The values are quite 
close and possible explanations for the small differences could be: (1) variation between 
activities of the rat liver CPR we used and the human CPR they used, (2) differences in the 
experimental conditions , and (3) lower concentration of CPR (we had a 20 μM post-mix volume 
and human CPR was at 10 μM post mix).   From these data, we can see that the values of K1, 
K2, and K3 are very similar despite the increasing concentrations of NADPH added (however, 
relative absorbance changes do vary). This demonstrates that the electron transfer observed 
likely derives from rate limiting steps that are independent of NADPH concentration and reliant 
more on CPR concentration. Had the binding of NADPH been rate limiting, one would expect 
that one or both of the observed rates would increase with increasing NADPH concentration.  
Thus, the very rapid rate of NADPH binding, as proposed above in our simple mechanism of 
Figure 19, was confirmed and supports the earlier assertion that hydride transfer reflects the 
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first observed rate limiting step.   Another aspect of this reaction that is interesting, besides the 
multiple phases, is that the A2 value at 590 nm for the 40 μM trial that represents an increase 
in absorbance and, therefore, an increase in the amount of semiquinone being formed. 
Contrastingly, the A2 value at both trials of excess NADPH reflects a loss of absorbance at 590 
nm and a loss of the semiquinone state. The loss of semiquinone at excess NADPH is due, 
presumably, to the addition of more than two electrons into CPR from another NADPH, taking 
the flavins to the fully reduced, hydroquinone state [13,19]. There does appear to be a third 
phase present in the RHR, however, for WT CPR (and for the rest of the CPR variants) the third 
phase is occurring after the 1.0 sec time point with a rate that is about three orders of 
magnitude slower than the rate of reduction and the turnover number from the SSTO assays. 
Thus, this phase most likely is not catalytically relevant and there is even some data to suggest 
that this phase is an artifact of re-oxidation of CPR by atmospheric oxygen not removed during 
argon sparging (unpublished Swenson lab data). Additionally, as will be shown in the kinetics, 
this phase usually does not represent a large or fast absorbance change, compared to the first 
two rates (particularly at stoichiometric NADPH). Therefore, this third phase, although 
represented in fitting, will not be discussed in detail in this thesis. 
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Wt CPR 
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20d. 
 
Wild-Type CPR 
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Figure 20- The thick black lines are the averaged reductive half-reaction traces between 40 μM 
WT CPR and 40 μM (20a), 200 μM (20b) and 400 μM (20c) NADPH measured at 450 nm and 590 
nm. The 590 nm trace is the upper trace and 450 nm is the lower trace for all graphs. The thin 
red line on each graph represents the triple exponential, 7 parameter fit to the data and the 
related rates and relative absorbance values can be seen in the table in 20d. 
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Reductive half-reaction of G141A CPR: The RHR of G141A CPR was evaluated using the same 
experimental approach and analyses as for the WT CPR. The triplicate stopped-flow reaction 
traces at 40, 200, and 400 μM NADPH for both 450 nm and 590 nm were averaged and these 
combined traces were transferred to SigmaPlot for curve fitting and analysis (see Figure 21a-c). 
Like that for WT CPR, the kinetic traces for the RHR of G141A CPR for each NADPH 
concentration was best fit to a triple exponential, 7 parameter equation and the observed rates 
and relative absorbance changes can be seen in the table in Figure 21d. The kinetic parameters 
obtained for G141A were very similar to that of WT CPR with the general comment that the 
reaction was slightly slower (especially at stoichiometric NADPH). Considering how minor an 
alteration the alanine substitution represents, the similarity to the WT CPR was expected. 
Minor differences were observed for the K2 and K3 values for the trials with stoichiometric 
NADPH. The G141A K2 value of 2.95 s-1 is just a little less than half the 5.72 s-1 rate observed for 
WT and the K3 value is very small at 0.0048 for G141A, which is not even a hundredth of the 
0.587 value observed in WT CPR. Although these values are not especially different, it is 
possible that this step involves the FMNsq and therefore the G141A alteration. 
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G141A CPR  
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G141A CPR 
       
         
 
40 uM NADPH 
 
200 uM NADPH 
 
400 uM NADPH 
 
450nm 590nm 
 
450nm 590nm 
 
450nm 590nm 
         A1 0.179 -0.0471 
 
0.150 -0.0830 
 
0.157 -0.0968 
K1 32.6 
  
29.7 
  
27.6 
 
         A2 0.0720 -0.0367 
 
0.172 0.0502 
 
0.176 0.0788 
K2 2.95 
  
7.73 
  
7.07 
 
         A3 -0.116 0.0119 
 
0.0332 -0.0342 
 
0.0359 -0.0352 
K3 0.0048 
  
0.0416 
  
0.0442 
  
 
Figure 21- The thick black lines are the averaged reductive half-reaction traces between 40 μM 
G141A CPR and 40 μM (21a), 200 μM (21b) and 400 μM (21c) NADPH measured at 450 nm and 
590 nm. The 590 nm trace is the upper trace and 450 nm is the lower trace for all graphs. The 
thin red line on each graph represents the triple exponential, 7 parameter fit to the data and 
the related rates and relative absorbance values can be seen in the table in 21d. 
 
 
 
 
 
 
 
 
73 
 
Reductive half-reaction of G141T CPR: The RHR for G141T CPR was also similarly evaluated.  The 
triplicates of reaction traces at 40, 200, and 400 μM NADPH at both 450 nm and 590 nm were 
averaged and these combined traces (see Figure 22a-c) were again transferred to SigmaPlot for 
fitting to a triple exponential, 7 parameter equation (see table in Figure 22d). Comparison of 
the reaction traces and the rate constants from the fit show that, like G141A CPR, the derived 
rates for each of the three phases observed for the RHR of G141T CPR were very similar to that 
of WT CPR. In the trial with stoichiometric NADPH, the K1 values are very close at 42.6 and 43.1 
s-1 for WT and G141T, respectively; however, the K2 and K3 values of 2.84 and 0.0210 s
-1
 are 
lower for G141T than for WT CPR (5.72 and 0.587 s-1). Although the differences in K2 and K3 are 
again not especially substantial, they represent a continued trend from the G141A CPR data. In 
contrast to G141A, the K1 and K2 values for G141T CPR increase in the reactions with excess 
NADPH. To reiterate an important point obtained from analyses, the time courses for the RHR’s 
of WT, G141A, and G141T CPR were observed to be quite similar but with minor changes to the 
apparent rates observed for the second and third phases, i.e. K2 and K3.  
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22d- 
G141T CPR 
       
         
 
40 uM NADPH 
 
200 uM NADPH 
 
400 uM NADPH 
 
450nm 590nm 
 
450nm 590nm 
 
450nm 590nm 
         A1 0.163 -0.0499 
 
0.144 -0.0712 
 
0.158 -0.0867 
K1 43.1 
  
44.5 
  
38.2 
 
         A2 0.0389 -0.0202 
 
0.191 0.0346 
 
0.198 0.0721 
K2 2.84 
  
8.69 
  
7.30 
 
         A3 -0.0416 0.0170 
 
0.0167 -0.0177 
 
0.0112 -0.0173 
K3 0.0210 
  
0.0221 
  
0.0264 
  
Figure 22- The thick black lines are the averaged reductive half-reaction traces between 40 μM 
G141T CPR and 40 μM (22a), 200 μM (22b) and 400 μM (22c) NADPH measured at 450 nm and 
590 nm. The 590 nm trace is the upper trace and 450 nm is the lower trace for all graphs. The 
thin red line on each graph represents the triple exponential, 7 parameter fit to the data and 
the related rates and relative absorbance values can be seen in the table in 22d. 
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Reductive half-reaction of G141del CPR: The averaged time courses RHR for the G141del CPR 
variant at 40, 200, and 400 μM NADPH at both 450 nm and 590 nm  (see Figure 23a-c) were 
again best fit to a triple exponential, 7 parameter equation (see table in Figure 23d). A striking 
difference was noted for the reaction profile for this variant at the stoichiometric amount 
NADPH, especially at 590 nm, compared to the others. At 590 nm for the other variants, there 
are two major phases associated with the formation of the semiquinone state: (1) the major 
and most rapid phase represented by K1 and (2) slower and minor phase represented by K2. In 
contrast, G141del CPR has the initial phase of semiquinone formation just like the other CPR 
variants, however, the K2 represents a rapid loss of absorbance at 590 nm. This observation 
indicates that the disemiquinoid species of G141del CPR, which is being formed (K1 = 69.8 s-1), 
is rapidly lost (K2 = 16.3 s-1). This transient formation of the semiquinone is unique to G141del, 
but these results were not wholly unexpected since the anaerobic redox titrations of G141del 
FBD showed very little stable formation (<10%) of the neutral semiquinone state. Additionally, 
in all RHR’s the K1 of G141del CPR is larger than the WT CPR, however, in excess NADPH the K2, 
A2 and K3, A3 values are essentially the same for WT CPR and the reaction traces are similar 
looking as well.  
The two differences found in the RHR’s for G141del CPR are particularly interesting 
when compared to those of wild-type BMR (BM-3’s diflavin reductase domain). Recall that the 
FMN-binding loop of G141del resembles that of BM-3 in that it is missing the conserved glycine 
and is shorter and less flexible than the binding loop of WT CPR. With this in mind, the observed 
rates of K1 for WT BMR is >700 s-1 in excess NADPH according to Munro et al. (and in this lab 
numbers ~300-400 s-1 are obtained) and the semiquinone formation in BMR is only transient 
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just as it is in G141del CPR [12,24]. BMR’s rate of K1 for stoichiometric amounts of NADPH was 
159 s-1 at 590 nm and also there was also only transient semiquinone formation [Unpublished 
Swenson Lab data obtained by myself]. The reaction traces for G141del CPR are mostly similar 
to WT CPR, however especially at stoichiometric NADPH, G141del shows characteristic of WT 
BMR RHRs. The unique nature of the rapid loss of the disemiquinoid state by G141del CPR will 
be explored in depth later in this thesis.  
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23d- 
G141del CPR 
       
         
 
40 uM NADPH 
 
200 uM NADPH 
 
400 uM NADPH 
 
450nm 590nm 
 
450nm 590nm 
 
450nm 590nm 
         A1 0.0530 -0.0291 
 
0.0815 -0.0339 
 
0.078 -0.0362 
K1 69.8 
  
65.6 
  
72.6 
 
         A2 0.0687 0.0257 
 
0.276 0.0429 
 
0.347 0.0473 
K2 16.3 
  
7.20 
  
6.86 
 
         A3 -0.0378 -0.0010 
 
0.0709 -0.0125 
 
0.0618 -0.0119 
K3 0.0212 
  
0.275 
  
0.2743 
  
 
 
         
Figure 23- The thick black lines are the averaged reductive half-reaction traces between 40 μM 
G141del CPR and 40 μM (23a), 200 μM (23b) and 400 μM (23c) NADPH measured at 450 nm 
and 590 nm. The 590 nm trace is the upper trace and 450 nm is the lower trace for all graphs. 
The thin red line on each graph represents the triple exponential, 7 parameter fit to the data 
and the related rates and relative absorbance values can be seen in the table in 23d. 
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Reductive half-reaction of WT CPR with competitive inhibition of NADP+:  The above described 
results point to some significant differences in the mechanism of electron transfer and 
distribution over the course of the RHR, especially for the G141del variant.  However, as 
discussed at beginning of this section, the reactions traces being multiphasic do not conform to 
the simple reaction mechanism shown in Figure 19.  In order to interpret the observed changes 
in response to the Glycine-141 alterations, a series of experiments were performed to explore 
the basis for multiple phases of reduction seen in all the CPR variants, with a particular interest 
in WT CPR. Although the second phase of reduction seen at 450 nm and 590 nm for 
stoichiometric NADPH at WT CPR was different from the expected results, the second phase 
seen in excess NADPH has been explained. Previously published stopped-flow 
spectrophotometric studies at excess NADPH attributed the second phase of reduction to the 
release of NADP+, subsequent binding of a second NADPH molecule, and finally a transfer of an 
additional hydride to CPR taking the both flavins from the semiquinone state to the 
hydroquinone state [13,19]. Our reaction time courses at the higher concentrations of NADPH 
in excess of the reductase, i.e. 200 and 400 μM NADPH, support this conclusion in WT CPR, with 
a second phase corresponding to loss of absorbance at 590 nm and loss of absorbance at 450 
nm. However, our results for the trials using stoichiometric amounts of NADPH also contain a 
second phase of reduction that is related to a loss of absorbance at 450 nm (loss of oxidized 
flavin), but an unexpected continuation of the increase in the absorbance at 590 nm (formation 
of the semiquinone). Because this second phase seems to be occurring at a similar rate at all 
NADPH concentrations (see Figure 20d), it is tempting to speculate that this phase is associated 
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with the release of NADP+ and subsequent effects on the rate of distribution of the electrons 
between the two flavin cofactors. 
 To test this hypothesis that the second phase is related to NADP+ binding and/or 
release, a stopped-flow experiment was performed in which 40 μM of WT CPR was reacted 
with 40 μM NADPH with increasing concentrations of NADP+(40, 200, or 400 μM). The expected 
result, if there is competitive binding, is that rates (K1, K2 and K3) should decrease as NADP+ 
concentration increases. The results conform to the expectations and as in previous RHRs, the 
450 nm and 590 nm absorbance data were again fit to a triple exponential, seven parameter 
rate equation (see Figure 24). The rates show a steady decrease as the NADP+ concentration 
increases as follows: K1 = 42.6, 17.6, 6.03, 2.40 s-1; K2 = 5.72, 1.45, 0.755, 0.33 s-1; and K3 = 
0.587, 0.0016, 0.0015, 0.002 s-1 (these values are for 0, 40, 200, and 400 μM NADP+, 
respectively). Note that there is an exception to decreasing rate with K3 values, but again these 
values were almost too slow to be catalytically relevant. The decrease in the rate for the first 
phase (K1) was anticipated as this phase has been attributed to the hydride transfer from 
NADPH to the FAD.  It seems very reasonable that NADP+ would compete for the NADPH 
binding site. It has been shown that the adenosine moiety of the NADPH molecule is the 
primary binding component and this allows for binding of the similar molecules 2’,5’-ADP [13] 
and NADP+ [6,15] to CPR. Therefore, it seems likely that NADP+, which is at increasing 
concentration as the reaction proceeds, present in the reaction solution could be competing 
with NADPH binding and, consequently, altering the progressive rate of further reduction of the 
flavins. 
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 Following this experiment, we realized that although the observed rates were inversely 
related to the concentration of NADP+, this did not technically show that competitive binding 
was causing the decreased rates. A second explanation is that the NADP+ is binding tightly to 
WT CPR and forming a non-functional version of the enzyme, not that NADP+ is just occupying 
the binding site of NADPH. To provide further support for the competitive binding hypothesis, a 
second set of stopped-flow spectrophotometric studies were performed, but in this set 40 μM 
WT CPR was reacted with 200 μM NADP+ with increasing concentrations of NADPH: 40, 200, or 
400 μM. The premise was that if competitive binding was in play then increasing the 
concentration of NADPH in the reaction solution should make NADPH binding more likely, 
effectively decreasing the chances of NADP+ occupying the binding site and increasing the rate 
of WT CPR reduction. Again, similar triphasic reaction time courses were obtained (see Figure 
25). However, in the presence of NADP+, the increasing concentration of NADPH increased the 
observed rates as follows: K1 = 4.63, 7.46, 14.5 s-1; K2 = 0.548, 3.10, 6.43 s-1; and K3 = 0.0024, 
0.0159, 0.022 s-1 (these values are for 40, 200, and 400 μM NADPH, respectively).  Thus, these 
results are consistent with a competition between NADPH and its oxidation product NADP+ 
which, again, can easily be rationalized for the first and fastest phase associated with hydride 
transfer. 
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40, 200, & 400 uM NADP + 40 uM NADPH shot against 40 uM WT CPR 
         
 
40 uM NADP 
 
200 uM NADP 
 
400 uM NADP 
 
450nm 590nm 
 
450nm 590nm 
 
450nm 590nm 
         A1 0.100 -0.0338 
 
0.0926 -0.0349 
 
0.081 -0.0302 
K1 17.8 
  
6.03 
  
2.4 
 
         A2 0.0613 -0.0216 
 
0.0777 -0.0267 
 
0.085 -0.0325 
K2 1.45 
  
0.755 
  
0.33 
 
         A3 -0.100 -0.0156 
 
-0.0645 -0.0189 
 
-0.0181 -0.0156 
K3 0.0015 
  
0.0016 
  
0.002 
  
Figure 24- This table represents the reductive half-reaction of WT CPR with stoichiometric 
NADPH in the presence of increasing amounts of NADP+. As a reference, the rate values for the 
stoichiometric reductive half-reaction of WT CPR without NADP+ are K1 = 42.6, K2= 5.72, and K3 
= 0.587. 
 
 
40uM WT CPR + 200uM NADP shot against  40, 200, and 400 uM NADPH 
         
 
40 uM NADPH 
 
200 uM NADPH 
 
400 uM NADPH 
 
450nm 590nm 
 
450nm 590nm 
 
450nm 590nm 
         A1 0.137 -0.0485 
 
0.280 -0.084 
 
0.112 -0.0931 
K1 4.63 
 
  7.46 
  
14.5 
 
         A2 0.0711 -0.0282 
 
0.0536 -0.0036 
 
0.262 0.0247 
K2 0.548 
 
  3.10 
  
6.43 
 
         A3 -0.0998 -0.0179 
 
0.0575 -0.0245 
 
0.0593 -0.037 
K3 0.0024 
 
  0.0159 
  
0.022 
  
Figure 25- This table represents the reductive half-reaction of WT CPR with 200 μM NADP+ in 
the presence of increasing amounts of NADPH. As a reference, the rate values for the 
stoichiometric reductive half-reaction of WT CPR without NADP+ are K1 = 42.6, K2= 5.72, and K3 
= 0.587. 
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However, competitive binding does not fully explain the second or third phase of 
reduction present in WT CPR at stoichiometric NAPDH. These phases would seem to occur after 
the initial reduction of the FAD and more so with the second phase which seems to be 
associated with the redistribution of the two electrons between the two flavin cofactors as the 
disemiquinoid species is formed.  Therefore, an even more complex mechanism must be 
developed to explain these portions of the reaction trace of the RHR.  Nonetheless, these 
experiments just discussed (as seen in the kinetic modeling) provided an important step in the 
mechanism of electron transfer in WT CPR.   An expanded mechanism and efforts to fit the data 
to this mechanism will be discussed in detail below. 
Reductive half-reaction of G141A, G141T and G141del CPR with competitive inhibition of NADP+: 
Similar studies of competitive binding in the WT CPR were performed with G141A, G141T and 
G141del CPR. The results were very similar in that increasing the amount of NADP+ in RHR 
experiments was found to decrease all observed rates of reduction. One observation of interest 
is that during an experiment of 40 μM G141del CPR with 80 μM NADPH and increasing 
concentrations of NADP+ (40, 200, or 400 μM) the overall data could not be globally fit because 
although the absorbance changes at 590 nm appeared the same as the stoichiometric reaction, 
the absorbance change showed that a second round of reduction was occurring with G141del. 
This turnover (a second round or reduction) was unseen in identical experiment performed on 
G141A and G141T CPR. At the time this observation was unremarkable, but as will be shown in 
the kinetic modeling results, this information lends itself to support the unique flavin reduction 
characteristics of G141del CPR.   
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Kinetic modeling of the reductive half-reaction in CPR: As mentioned, a simple model of electron 
transfer shown in Figure 19 in CPR with stoichiometric NADPH cannot adequately explain the 
multiphasic results obtained for the RHR. This model does not account for the release of the 
oxidation product NADP+ and 1) the possibility for competitive binding between NADPH and 
NADP+ and 2) the effect of NADP+ either being bound to or released differentially from the 
various redox states of the CPR enzyme during the course of the reaction.  Our next task was to 
devise a mechanism based on the redox states observed for FAD and FMN that was capable of 
fitting the RHR absorbance data at 450 nm and 590 nm for all CPR variants, especially at 
stoichiometric levels of NADPH.  As an exceptional aid in this process, the KinTek® Global Kintek 
Explorer software was employed.  This very sophisticated software program (kindly loaned to 
us by Dr. Zucai Suo) provides the flexibility of formulating often complex reaction mechanisms 
which then uses integration algorithms to simulate the reaction time course of the reaction.  
The program allows one to plot the time course for the formation and conversion of every 
reaction intermediate involved.  By applying known extinction coefficients for each species, in 
this case at 450 nm and 590 nm, a simulated time course can be calculated for both 
wavelengths. But, most importantly, the program can be used to establish the individual 
microscopic rate constants for each step of the proposed model that are consistent with the 
reaction time course.  The program also allows for the simultaneous “global fitting” of multiple 
data sets generated for the same enzyme, but under different conditions such as various 
substrate concentration and, in our case, in the presence of different concentrations of NADP+.  
Thus, this powerful program very effectively allows us to acquaint our kinetic data to specific 
biochemical steps. The specific goals of these modeling studies was to: (1) determine what was 
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causing the second phase of reduction in all CPR variants and (2) find out what was causing the 
disparity between the semiquinone formation in G141del CPR and the other variants. To 
achieve these goals we first had to build a mechanism that could fit the reaction traces for WT, 
G141A, G141T and G141del CPR variants and then we could compare the microscopic rate 
constants to identify the differences in electron transfer between the variants.  
Throughout the process of modeling reactions, we tried to keep the kinetic model as 
simple as possible and additions made to the model always had a basis in either our own 
experimentation or conclusions made from literature sources. The growth of our model went 
through four iterations: (1) Minimal Model, (2) Moderate Model Mk.I, (3) Moderate Model 
Mk.II, and (4) the Full Model (see Figure 26).  We began with the minimal model of electron 
transfer representing the simplest version and the general mechanism of two electron transfer 
into and within CPR and, as previously mentioned (Figure 19 and 26a), this model could not fit 
the data. The mechanism was made more complex by adding the release of NADP+ from the 
FADhq/FMNox and the FADsq/FMNsq redox states to generate the Moderate Model Mk.I. The 
idea that the enzyme character changes with or without NADP+ relates back to the fact that 
binding/release of NADP+ causes conformational changes in CPR which effect activity [6,10,15]. 
Additionally, the release of NADP+ from WT CPR creating two functional forms of the reduced 
enzyme in kinetics studies has been hypothesized by Gutierrez et al. [19]. The Moderate Model 
Mk.II incorporated the competitive binding of NADP+ (released from CPR after hydride transfer) 
to the NADPH-binding site. The evidence for this step came from our experimentation 
described in the section, “Reductive half-reaction of WT CPR with competitive inhibition of  
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26e- The Full Model 
 
 
Figure 26- These four represent the four models of the reductive half-reaction created, 
including the Minimal Model (a), the Moderate Model Mk.I (b), the Moderate Model Mk.II (c), 
and the Full Model (d). The Full Model (expanded in 26e) is the mechanism which best 
represents the electron transfer in WT, G141A, G141T, and G141del CPR.  
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NADP+.” However, despite the additions to the model, the fits to the WT CPR reaction traces at 
450 nm and 590 nm were unsatisfactory. The addition of the FADox/FMNhq redox species with 
and without the bound NADP+ in the Full Model gave us a model that quite adequately fit the 
time courses for the reductive half-reaction for the WT CPR (and the other CPR variants as well) 
for all of the reaction condition studies (see Figure 26e, for a larger view of the Full 
Mechanism). The formation of the FADox/FMNhq was added after the consideration that in 
many diflavin reductases (BM-3 for example) the disemiquinoid species is formed only 
transiently before both electrons derived from the NADPH travel to and accumulate on the 
FMN cofactor. It seemed likely that in CPR there might not be full stabilization of the 
disemiquinoid species and an eventual formation of the FADox/FMNhq. This was certainly likely 
to be the case for the G141del variant where the disemiquinoid was only formed transiently 
(see reaction trace 23a at 590 nm). 
 The Full Model was used to perform a global fit to the reaction time courses at 450 nm 
and 590 nm at stoichiometric amounts of NADPH for WT CPR. The fit to this data had very little 
error and there was only a small difference between the experimentally obtained molar 
extinction coefficients from the Full Model and the initially calculated extinction coefficients 
based on literature values. After this initial fitting, the acquired microscopic rate constants were 
used as a starting point for the global fitting of the half-reactions of WT CPR with stoichiometric 
levels of NADPH and 0, 40, and 200 μM NADP+ (see Figure 27, 28). The Full Mechanism was 
again found to accurately fit all three half-reaction trials.  In addition, the Kd values calculated 
from the appropriate forward and reverse microscopic rate constants for those steps involving 
nucleotide binding were quite comparable to literature values.  The calculated Keq values for the 
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other steps were also reasonable. Thus, the global fitting of all of the data for the WT CPR to 
this mechanism was very gratifying and provides substantial confidence in the devised 
mechanism.  Furthermore, conclusions can be drawn from the microscopic rate constants 
obtained from the fitting. First, the rate k2+ corresponds to the rate of hydride transfer and has 
a value of 43 s-1, which is very close to the observed rate of 42.6 s-1 attributed to hydride 
transfer. Additionally, the second order rate constant for NADPH binding, k1+, of 85.6 uM-1 s-1 
combined with the initial concentration of the NADPH generates rates that are, in fact, much 
higher than hydride transfer as proposed from the absence of a NADPH concentration 
dependence for this initial reductive phase.  Second, K3+, which represents the transfer of one 
electron from the FAD to FMN to form the disemiquinoid species was shown to be 124 s-1 from 
the fitting, which is also faster than hydride transfer, again consistent with hydride transfer 
being the rate limiting step and explains why the formation of the disemiquinoid species is 
concomitant with hydride transfer. Thirdly, it became very clear, through the essential nature 
of the NADP+ competitive binding step (step K7 in the model) and the ability of the model to fit 
the NADP+ addition trials, that NADP+ competitively binding with NADPH does play a role in the 
overall rate of reduction in WT CPR and in particular the second phase. Finally, and perhaps one 
of the most important revelations is that the second and third phases of the reduction observed 
in the RHR cannot be attributed specifically to any single microscopic rate constant. After many 
iterations of fitting and observation of species formation within the KinTek program it has 
become clear that the observed rates of the second and third phase are the combination of 
several microscopic rates.   
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Wt CPR and Stoich NADPH and various NADP+- Global fit of 450 + 590 data  
 
           Kintek Global Fit Data 
        Rate K1 K2 K3 K4 K5 K6 K7 K8 K9 K10 
K+ 85.6 43 124 12.9 0.532 32.3 39.6 0.0717 125 190 
K- 229 0.17 53.7 0.109 0.399 0.155 58.2 0.01 62.6 134 
           Kd (uM) 2.7   118.3  208.4 1.47 7.2   
Lit. Kd (uM) 6.5 - - - - - 0.76 - - - 
           Keq (uM)  252.9 2.3  1.3    2.0 1.4 
 
Molar Extinction Coefficients (μM
-1 
cm
-1
) 
    
 
FADox/FMNox FADhq/FMNox FADsq/FMNsq FADox/FMNhq 
Initially Calculated: 
    450nm: 0.0204 0.0124 0.0059 0.0124 
590nm: 0 0 0.0092 0 
     Experimentally Obtained: 
    0uM NADP
+ 
to 40uM NADPH 
    450nm: 0.0021 0.0133 0.0059 0.0133 
590nm: 0 0 0.0102 0 
40uM NADP
+ 
to 40uM NADPH 
    450nm: 0.0205 0.0154 0.0065 0.0154 
590nm: 0 0 0.0078 0 
200uM NADP
+ 
to 40uM NADPH 
    450nm: 0.0204 0.0138 0.0068 0.0138 
590nm: 0 0 0.0094 0 
 
 
Figure 27a. The top chart shows the microscopic rate constants that were obtained from fitting 
the WT CPR reductive half-reactions with differing concentrations of NADP+. The bottom chart 
shows the molar extinction coefficients obtained from fitting the experimental data.  
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Figure 27b. This data reflects the global fitting of the WT CPR data with and without NADP+ 
added. The blue and white lines represent the 450 nm and 590 nm reaction traces, respectively, 
for the 0 μM NADP+ RHR. The yellow and green lines represent the 450 nm and 590 nm reaction 
traces, respectively, for the 40 μM NADP+ RHR. The red and purple lines represent the 450 nm 
and 590 nm reaction traces, respectively, for the 200 μM NADP+ RHR.  
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Global fit of reductive half-reactions of Glycine-141 variants to the initial reduction steps within 
the Full Model: The Full Model (Figure 26e) was used in the globally fitting of the reaction time 
courses at 450 nm and 590 nm for the RHR’s for each of the G141A, G141T, and G141del CPR 
variants with the stoichiometric amounts of NADPH as the reductant as done for WT CPR. With 
a few very notable exceptions, most often for the G141del variant, the microscopic rate 
constants, Kd values, Keq values, and experimentally obtained molar extinction coefficients were 
nearly always very similar to those of WT CPR.  A summary of all rate constants and parameters 
obtained from the fitting process are summarized along with graphical fitting results for each 
variant in Figures 28-30. Much like WT CPR, many of the same conclusions can be drawn from 
the microscopic rate constants and the overall mechanism. In this section, those parameters 
that are part of the initial reduction steps will be summarized with a separate discussion later 
for those differences noted primarily for the G141del variant. 
 The value for the microscopic rate constant k2+ (representing hydride transfer) has a 
value of 55.7 s-1 and 66.2 s-1 for the G141A and G141T variants, respectively.  Both values 
conform reasonably well to the observed rate for the first phase of reduction which was 32.6 s-1 
and 43.1 s-1 for each variant, respectively.  The k2+ values for both variants are perhaps slightly 
higher than that obtained for the WT enzyme (43 s-1).  As with WT, this rate constant does 
remain lower than the product of the second order rate constant k1+ and the initial NADPH 
concentration as well as k3+ associated with the formation of the disemiquinoid species, again 
indicating that this step is rate limiting in both variants.  Perhaps of significance, the k2+ value 
for the G141del variant was somewhat smaller (11.8 s-1) suggesting that this alteration may 
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have some influence on this reductive step.  The k3+ values for all three variants are similar to 
that of WT.    
Secondly, the Kd value calculated from k7+ and k7- is low (~1.5-1.8 μM) and in the same 
range as that calculated for NADPH (from k1+ and k1-) for both the G141A and G141T variants.  
Both the Kd values (for the binding of NADPH and NADP
+) compare favorably with literature 
values determined by other methods although the Kd calculated for NADP
+ for the G141del 
variant tended to be somewhat higher.  Nevertheless, these observations are consistent with 
the presence of the competitive binding of NADP+ to the initial oxidized state of reductase, 
supporting the importance of including this process in the interpretation of the overall electron 
transfer mechanism. The similarity for these aspects of the electron transfer mechanism is 
expected considering they involve the FAD-binding domain which is identical for all CPR variants 
and well separated from the Glycine-141 alteration occurring in the separate FMN-binding 
domain. Finally, as was the case for the WT CPR, the second and third slower observed phases 
of reduction time course appear to be the combination of several microscopic rate constants in 
all three variants.  Thus, this minor modification resulted in only relatively small changes, if any, 
to the microscopic rate constants derived for each step in this mechanism. 
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G141A CPR and Stoich NADPH- Global fit of 450nm + 590nm data. 
   
           Kintek Global Fit Data 
         Rate K1 K2 K3 K4 K5 K6 K7 K8 K9 K10 
k+ 85.6 43 124 12.9 0.532 32.3 39.6 0.0717 125 190 
k- 229 0.17 53.7 0.109 0.399 0.155 58.2 0.01 62.6 134 
           Kd (uM) 2.7   118.3  208.4 1.47 7.2   
Lit. Kd (uM) 6.5 - - - - - 0.76 - - - 
           Keq (uM)  252.9 2.3  1.3    2.0 1.4 
 
Molar Extinction Coefficients (μM-1cm-1) 
   
 
FADox/FMNox FADhq/FMNox FADsq/FMNsq FADox/FMNhq 
Initially Calculated: 
    450nm: 0.0204 0.0124 0.0059 0.0124 
590nm: 0 0 0.0092 0 
     Experimentally Obtained: 
    0uM NADP
+ 
to 40uM NADPH 
    450nm: 0.0203 0.0120 0.0059 0.0120 
590nm: 0 0 0.0095 0 
 
 
Figure 28a- The top chart shows the microscopic rate constants that were obtained from fitting 
the G141A CPR reductive half-reaction performed with stoichiometric NADPH. The bottom 
chart shows the molar extinction coefficients obtained from fitting the experimental data.  
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Figure 28b. This data reflects the global fitting of the G141A CPR data without NADP+ added. 
The yellow and blue lines represent the 450 nm and 590 nm reaction traces, respectively, for 
the RHR with stoichiometric amounts of NADPH.  
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G141T CPR and Stoich NADPH- Global fit of 450nm + 590nm data 
  
           Kintek Global Fit Data 
         Rate K1 K2 K3 K4 K5 K6 K7 K8 K9 K10 
k+ 129 66.2 131 7.88 1.4 12 35.8 0.397 151 178 
k- 848 2.99 62.8 1.82 1.03 0.0187 66.2 0.024 106 115 
           Kd (uM) 6.6   4.3  641.7 1.85 16.5   
Lit. Kd (uM) 6.5 - - - - - 0.76 - - - 
           Keq (uM)  22.1 2.1  1.4    1.4 1.5 
 
Molar Extinction Coefficients (μM-1cm-1) 
   
 
FADox/FMNox FADhq/FMNox FADsq/FMNsq FADox/FMNhq 
Initially Calculated: 
    450nm: 0.0204 0.0124 0.0059 0.0124 
590nm: 0 0 0.0092 0 
     Experimentally Obtained: 
    0uM NADP
+ 
to 40uM NADPH 
    450nm: 0.0203 0.0120 0.0059 0.0120 
590nm: 0 0 0.0095 0 
 
Figure 29a- The top chart shows the microscopic rate constants that were obtained from fitting 
the G141T CPR reductive half-reaction performed with stoichiometric NADPH. The bottom 
chart shows the molar extinction coefficients obtained from fitting the experimental data.  
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Figure 29b. This data reflects the global fitting of the G141T CPR data without NADP+ added. 
The yellow and blue lines represent the 450 nm and 590 nm reaction traces, respectively, for 
the RHR with stoichiometric amounts of NADPH.  
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G141del CPR and Stoich NADPH- Global fit of 450nm + 590nm data 
  
           Kintek Global Fit Data 
         Rate K1 K2 K3 K4 K5 K6 K7 K8 K9 K10 
k+ 64.5 11.8 81 11.9 1.06 365 15.5 0.00829 2.78 238 
k- 320 0.653 37.6 1.03 0.864 12.9 101 0.00234 1.25 0.341 
           Kd (uM) 5.0   11.6  28.3 6.52 3.5427   
Lit. Kd (uM) 6.5 - - - - - 0.76 - - - 
           Keq (uM)  18.1 2.2  1.2269    2.2 697.9 
 
Molar Extinction Coefficients (μM-1cm-1) 
   
 
FADox/FMNox FADhq/FMNox FADsq/FMNsq FADox/FMNhq 
Initially Calculated: 
    450nm: 0.0204 0.0124 0.0059 0.0124 
590nm: 0 0 0.0092 0 
     Experimentally Obtained: 
    0uM NADP
+ 
to 40uM NADPH 
    450nm: 0.0204 0.0147 0.0061 0.0147 
590nm: 0 0 0.0101 
 
      
Figure 30a- The top chart shows the microscopic rate constants that were obtained from fitting 
the G141del CPR reductive half-reaction performed with stoichiometric NADPH. The bottom 
chart shows the molar extinction coefficients obtained from fitting the experimental data.  
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Figure 30b. This data reflects the global of the G141del CPR data without NADP+ added. The 
yellow and white lines represent the 450 nm and 590 nm reaction traces, respectively, for the 
RHR with stoichiometric amounts of NADPH.  
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Analysis of the reliability of the microscopic rate constants obtained from the global fitting:  
Before proceeding to a more detailed discussion regarding the differences observed for 
primarily the G141del variant, it is important to establish for the reader the relative reliability of 
the microscopic rate constants and parameters obtained from the mechanistic global fitting 
analyses.  This process was deemed to be essential in order to gain confidence in the values for 
comparisons within the variants and in the final mechanistic interpretations.  The results of 
these analyses are represented by the collection of the microscopic rate constants into a color-
coded table of results shown in Figure 31.  The amount of error or flexibility of each set of rate 
constants was analyzed by determining the range of values for each constant that was allowed 
while retaining an accurate fitting of the reaction traces for each CPR variant. The table is color 
coded to illustrate the relative “flexibility” or variability that could be accommodated for each 
microscopic rate constants. The relatively inflexible values (yellow) cannot be altered without 
significantly increasing the error in the data fit, the moderately flexible (orange) rates can 
accommodate a small range without affecting the data fitting, and the very flexible rates (pink) 
allow large variation in the values. (Note that the values shown for the moderately and very 
flexible values are those obtained from the best fit of the data). Essentially, the flexibility of the 
rates serves as a benchmark for the degree of confidence and mechanistic importance that can 
be placed on those values. The inflexible rates were taken to be more integral to the 
mechanism considering their specificity and the significant effect of their change. Conversely, 
the very flexible rate constants, which can vary many orders of magnitudes, cannot be 
conclusively related to any interpretations on the effect of the glycine alterations on the 
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mechanism of electron transfer due to the fact that changing their rate has little effect on 
fitting the absorbance data. 
Therefore, with the reliability reflective in these flexibility “indices” in mind, the 
comparison of WT, G141A, and G141T CPR, led to some significant conclusions for the reductive 
half-reaction. Primarily, the values obtained for the microscopic rate constants K1, K2, K3, and 
K6 are relatively reliable (“inflexible”) and the examination of these rate constants suggest that 
in WT, G141A, and G141T the disemiquinoid state (the FADsq/FMNsq species with or without 
the bound NADP+) is the favored redox state. Following the rapid hydride transfer reflected in 
the rate constants K1 and K2, the formation of the disemiquinoid state reflected in K3. The K6 
value indicates that the forward reaction representing the eventual loss of the bound NADP+ is 
favored in these reductases.  Additionally, the equilibrium constants derived from the K9 and 
K10 values for these CPR variants are all close to equilibrium value of 1, with a slight favor for 
the FADox/FMNhq state, illustrating that although a second electron transfer from FAD to FMN 
is possible in these varieties, the prevalent state is the FADsq/FMNsq. This interpretation of the 
electron transfer mechanism can be confirmed by two sources: (1) using the KinTek software to 
simulate the formation of each redox species employing the established kinetic constants and 
parameters substantiates that the FMNsq/FADsq species with and without bound NADP+ is 
favored within a catalytically relevant timeframe, (2) the RHR with stoichiometric NADPH levels 
indicate that the reaction ends with the stable formation of predominately the FMNsq/FADsq 
species (high stable absorbance at 590 nm at the end of the time courses) and (3) the anaerobic 
redox titrations of WT, G141A, and G141T CPR show significant and stable semiquinone  
formation when two electron equivalents are added into each respective enzyme. 
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Global fit of the reductive half-reactions for the G141del CPR variant to all aspects of the Full 
Model: The RHR results obtained for the G141del CPR variant conformed very well to the Full 
Model just as for the other CPR variants (see Figure 30). As discussed, the similarity in the initial 
steps involving NADPH binding and hydride transfer was expected considering they involve the 
FAD-binding domain which should remain essentially unaltered in all CPR variants.  However, 
the evaluation of the RHR with stoichiometric NADPH levels, specifically at 590 nm, shows a 
profound difference in the reaction time course compared to the other variants in that the 
disemiquinoid state of this form of the G141del reductase forms only transiently, being rapidly 
lost in the second observed phase. Examination of the microscopic rates of G141del CPR, 
especially within the reliability compilation shown in Figure 31 (but also in Figure 30), a unique 
profile of electron transfer became apparent. Three microscopic rates are markedly different 
between G141del and the other CPR variants (note that values for the CPR variants referred to 
here are averages of WT, G141A, and G141T CPR; this is done for ease of comparison). The first 
rate constant is k6+ which is very inflexible and displays a value of 365 s-1 in G141del, greater 
than ten-fold higher than the rate of average value of 27 s-1 of the other CPR variants. The 
second rate constant k9+, which has a value of 2.78 s-1, is of interest because this value is 50-
fold less than that for the WT, G141A and G141T variants (average of 132 s-1). From the K9 
value, we can conclude that there is little formation of the FADox/FMNhq form of the enzyme 
with the NADP+ bound to the reductase. Finally, the Keq calculated from the k10+ and k10- 
values for G141del is 698 (k10+: 238 s-1/ k10-: 0.341 s-1), a value strongly favoring the transfer 
of a second electron from FADsq to FMNsq to form the FADox/FMNhq species. The Keq has a 1.4 
average (k10+: 180 s-1/ k10-: 130 s-1) for WT, G141A, and G141T CPR showing only a minor favor 
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for the formation of FADox/FMNhq. Combining these differences it can be concluded that the 
electron transfer in G141del CPR forms the disemiquinoid state relatively quickly, releases the 
NADP+ and then very quickly, and rather irreversibly, a second electron from the FADsq is 
transferred to the FMNsq causing the formation of the FADox/FMNhq.  This preferred electron 
transfer pathway is highlighted by the orange-colored arrows in Figure 32. This mechanism, in 
which the disemiquinoid species is only transiently formed, is significantly different from the 
preferred, stable formation of the disemiquinoid state observed for the WT, G141A and G141T 
CPR variants. This mechanism of electron transfer can be confirmed primarily by three sources: 
(1) simulating the formation of each redox species using the KinTek software confirms that for a 
catalytically relevant timeframe that the majority species formed is the FMNox/FADhq without 
NADP+, (2) the RHR for the G141del CPR in excess and stoichiometric NADPH show that before 
a second round of flavin reduction (shown by further decrease at 450 nm) takes place, the 
disemiquinoid species must first be converted to the FADox/FMNhq species (shown by loss of 
absorbance at 590 nm) in order that the fully oxidized FAD cofactor (FADox) can accept a 
second electron pair (as the hydride) as it must from NADPH, and (3) the anaerobic redox 
titration of the G141del FBD only shows only limited and transient disemiquinoid formation 
(<10%).   The implications of these rather substantial differences for this variant will become 
apparent in the next section. 
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Figure 31- Microscopic Rate Constant Flexibility Table 
  Wt CPR and Stoich NADPH and various NADP+- Global fit of 450 nm + 590 nm data  
  
         
  
Kintek Global Fit Data 
        
  
Rate K1 K2 K3 K4 K5 K6 K7 K8 K9 K10 
k+ 85.6 43 124 12.9 0.532 32.3 39.6 0.0717 125 190 
k- 229 0.17 53.7 0.109 0.399 0.155 58.2 0.01 62.6 134 
  
         
  
Kd (uM) 2.7   118.3  208.4 1.47 7.2    
Lit. Kd (uM) 6.5 - - - - - 0.76 - - - 
Keq (uM)   252.9 2.3   1.3       2.0 1.4 
           G141del CPR and Stoich NADPH- Global fit of 450 nm + 590nm data      
  
         
  
Kintek Global Fit Data 
        
  
Rate K1 K2 K3 K4 K5 K6 K7 K8 K9 K10 
k+ 64.5 11.8 81 11.9 1.06 365 15.5 0.00829 2.78 238 
k- 320 0.653 37.6 1.03 0.864 12.9 101 0.00234 1.25 0.341 
  
         
  
Kd (uM) 5.0   11.6  28.3 6.52 3.5427    
Lit. Kd (uM) 6.5 - - - - - 0.76 - - - 
Keq (uM)   18.1 2.2   1.23       2.2 697.9 
           G141A CPR and Stoich NADPH- Global fit of 450 nm + 590 nm data      
  
         
  
Kintek Global Fit Data 
        
  
Rate K1 K2 K3 K4 K5 K6 K7 K8 K9 K10 
k+ 197 55.7 141 11.1 0.0309 37 32.2 0.0252 121 191 
k- 1850 2.03 65.7 0.136 0.0223 0.0259 135 0.00162 91.8 143 
  
         
  
Kd (uM) 9.4   81.6  1428.6 4.19 15.6    
Lit. Kd (uM) 6.5 - - - - - 0.76 - - - 
Keq (uM)   27.4 2.1   1.4       1.3 1.3 
           G141T CPR and Stoich NADPH- Global fit of 450nm + 590nm data     
  
         
  
Kintek Global Fit Data 
        
  
Rate K1 K2 K3 K4 K5 K6 K7 K8 K9 K10 
k+ 129 66.2 131 7.88 1.4 12 35.8 0.397 151 178 
k- 848 2.99 62.8 1.82 1.03 0.0187 66.2 0.024 106 115 
  
         
  
Kd (uM) 6.6   4.3  641.7 1.85 16.5    
Lit. Kd (uM) 6.5 - - - - - 0.76 - - - 
Keq (uM)   22.1 2.1   1.4       1.4 1.5 
             → (+) = Inflexible Microscopic Rate Constant         
   → (++) = Moderately Flexible Microscopic Constant 
  
  
   → (+++) = Very Flexible Microscopic Rate Constant       
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Figure 32- This is a cartoon of 2 electron reduction of the CPR variants. The microscopic rate 
constants for WT, G141A, and G141T CPR for K6, K8, K9 and K10 have been averaged due to the 
similarity of their electron transfer mechanism. Essentially, these proteins ultimately form the 
disemiquinoid form with or (more likely) without NADP+. G141del CPR shows a different 
electron transfer mechanism, illustrated by the orange arrows. The rate constants K1, K2, K3, 
K4, K5, and K7 were similar between WT, G141A, G141T, and G141del and were averaged. 
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Oxidative Half-Reaction of WT CPR: The model for the RHR in CPR allowed for the 
determination of the mechanism of electron entrance into the enzyme and flow of electrons to 
and between the flavin cofactors. This mechanism, however, only accounts for a portion of the 
turnover of CPR. In an effort to complete our understanding of the entire electron transfer 
process for CPR, the oxidative half-reaction (OHR) was evaluated for the CPR variants. The OHR 
is of importance, especially in our investigation, because the FMN cofactor has been shown to 
be the electron donor to the final cytochrome acceptor in diflavin reductases.  In particular, 
there is strong evidence to suggest that the FMNsq is the redox state that allows for transfer of 
electron out of CPR. In fact, it has been suggested that the reductase is inhibited when “over-
reduced”, a state in which the FMNhq is formed *6,15,18+.  The primary goal of the OHR 
experiments were to determine the effect the Glycine-141 alterations had on the transport of 
electrons to cytochrome c acceptor in order to complete our understanding of this enzyme’s 
overall steady-state turnover activity. 
 The OHR was first performed with WT CPR and our primary focus was on the two 
electron transport process under stoichiometric concentrations of NADPH. It has been shown in 
previous experiments in this lab that the rate of reduction of CPR by NADPH is fast compared to 
the transfer of electron to cytochrome c (which is the rate limiting step).  This observation 
greatly simplifies the experiment because CPR does not have to be pre-reduced and maintained 
in a reduced state for extended periods of time, a feat that is difficult technically.  It was 
possible then, to premix the cytochrome c with NADPH in one of the stopped-flow syringes and 
cytochrome reduction is only initiated when oxidized CPR is rapidly added through the stopped-
flow instrument.  For each trial, about 10 μM of WT CPR was reacted with a solution of 10 μM 
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NADPH and increasing concentrations of cytochrome c: 10, 20, 40, 80, and 160 μM. In this lab 
and the literature [18], previous experiments with excess CPR have shown that the OHR follows 
a monophasic, first order reaction demonstrating Michaelis-Menten kinetics. The proposed 
mechanism depicted in Figure 34 shows that the after binding occurs between reduced CPR and 
oxidized cytochrome c a single electron is transferred from CPR to cytochrome c, reducing it 
and causing an absorbance change at 550 nm. Therefore, under pseudo-first order conditions 
(when the cytochrome is in excess) a monophasic reaction, relating to this electron transfer is 
expected.  Multiple concentrations of cytochrome c were used to assess the relationship 
between concentration and the rate of reduction and as a means to estimate the maximal rate 
achievable under saturating conditions. The experiment was performed in triplicate for each 
different concentration of cytochrome c and the reactions were monitored at 550 nm which 
reflects the change in absorbance between oxidized and reduced cytochrome c. The triplicate 
reaction traces were then combined into average reaction traces. For fitting and comparison, 
the 550 nm data was normalized to begin at zero and were plotted together (see Figure 33a). 
Upon first inspection, the reaction traces do appear to be monophasic with the apparent rate of 
cytochrome reduction increasing with the increasing concentration of cytochrome c (see Figure 
33a). To specifically identify and assign a rate to this phase, the data was transferred into the 
SigmaPlot graphical plotting program for iterative fitting. A fairly satisfactory fit, especially for 
the OHRs with higher cytochrome c concentrations, was achieved using a single exponential, 
three parameter fit (see Equation 6 and 7). 
(6) y = y0 + ae
-bx (this is the generic SigmaPlot equation) 
(7) A550 = y0+ A1
-kobs1t  
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10uM NADPH and Cytochome c
 
33b-  
OHR of WT CPR with Stoich. NADPH + Cyt C - 1 Exponential Fit 
     10 uM Cyt C +10 uM NADPH A1 K1 yo 
 550 nm: -0.0416 1.91 0.211 
 
     20 uM Cyt C +10 uM NADPH A1 K1 yo 
 550 nm: -0.0714 1.72 0.301 
 
     40 uM Cyt C +10 uM NADPH A1 K1 yo 
 550 nm: -0.0712 3.66 0.410 
 
     80 uM Cyt C +10 uM NADPH A1 K1 yo 
 550 nm: -0.0693 5.72 0.557 
 
     160 uM Cyt C +10 uM NADPH A1 K1 yo 
 550 nm: -0.0659 8.54 0.860 
 
     Figure 33- (a) The OHR reaction traces at 550 nm for the various cytochrome c concentrations. (b) The 
values from a single exponential, three parameter fit. 
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In equation 7, y0 represents final absorbance; A1 represent relative amplitude values; and kobs1 
represent the observed rate constants (referred to as K1). All of these values are shown in the 
table in Figure 33b. The apparent rates for 10, 20, 40, 80, and 160 μM were 1.91, 1.72, 3.66, 
5.72, and 8.54 s-1. These data were plotted (Figure 33c) and fit to a Michaelis-Menten 
hyperbolic fit (see Equation 8 and 9) 
(8) Y = (a*x)/(b+x) (this is the generic SigmaPlot equation) 
(9) Ki = (Kmax*[cytochrome c])/(Kd+[cytochrome c]) 
where Kmax is the maximum rate and Kd is the dissociation of cytochrome c. The values obtained 
for WT CPR were 15.1 s-1 and 63.1 μM for Kmax and Kd respectively, and  compared to the 
literature values our Kmax was very close to the 14 s
-1, however the Kd was about two fold higher 
than the 37 μM obtained by Grunau et al. (see Figure 33c) [15]. However, the literature values 
were obtained under different experimental conditions and with human CPR, both of which 
could affect the relative Kd. In addition to the analysis of rates, the absorbance changes of these 
reactions (obtained from absorbance values from the single exponential fit) were considered. It 
was expected that the two-electron reduced WT CPR in disemiquinoid state could reduce a 
stoichiometric equivalent of cytochrome c, meaning only a single electron, from the FMNsq 
would be transferred to a single bound cytochrome c. To determine if this was the case, 
absorbance changes at 550 nm were analyzed to establish the amount to cytochrome c actually 
reduced in the reaction. We observed that for WT CPR the amount of reduced cytochrome c 
that was formed was 57%, 80%, 78%, 73%, and 68% of the calculated amount expected for one 
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cytochrome reduced per CPR molecule at 10, 20, 40, 80, and 160 μM cytochrome c 
respectively, (see figure 33d).  
33c- 
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33d- 
Oxidative Half-Reaction of WT 
CPR 
 
 
Amount of Cyt C 
Reduced (uM) 
Percent Reduction Relative 
to Stoich. Cyt C Reduction 
10 uM Cyt C +10 uM NADPH 2.83 57% 
   20 uM Cyt C +10 uM NADPH 4.73 80% 
   40 uM Cyt C +10 uM NADPH 4.65 78% 
   80 uM Cyt C +10 uM NADPH 4.34 73% 
   160 uM Cyt C +10 uM NADPH 4.04 68% 
   
  
[WT CPR]- 11.88uM 
   Figure 33- (c) A Michaelis-Menten hyperbolic fit of the OHR data. (d) Relative amounts of cytochrome c 
reduced.  
 
 
 While this type of analysis provides a reasonable estimate of the process, it must be 
noted that at the low concentrations of cytochrome c, the experimental conditions do not 
conform to pseudo-first order conditions given the proposed reaction shown in Figure 34.  In 
fact, the fits of the stopped-flow data at the low concentrations were not fit exactly by a single 
exponential.    However, as expected, as concentrations got higher and in greater excess to the 
reductase the fits substantially improved.  At low concentrations of cytochrome c,  the 
cytochrome c and WT CPR concentrations had an effect on the rate of binding and therefore 
the rate of reduction, making the OHR a second order rate function depending on cytochrome c 
and WT CPR (robs = k[CytC][CPR]). However, at high enough concentrations of cytochrome c [40, 
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80, and 160 μM+ this value functionally becomes a constant due to the relatively minute 
concentration change in the OHR. Therefore, the function becomes pseudo-first order where 
the rate depends only on the concentration of WT CPR (robs = k’*CPR]). Use of multiple 
exponential fits can obviously improve the fit to the data, but such an approach in not validated 
by the proposed mechanism or the nature of the system under study so this approach, 
although tried, was justifiably abandoned.  Instead, KinTek kinetics modeling was again used to 
elucidate the full mechanism of electron transfer in the OHR and these efforts will be discussed 
later in this thesis.  
Oxidative Half-Reaction of G141A CPR: The OHR of G141A CPR was evaluated using the same 
experimental approach and analyses as for the WT CPR. The triplicate stopped-flow reaction 
traces at 10, 20, 40, 80, and 160 μM NADPH monitored at 550 nm were averaged and these 
combined traces were transferred to SigmaPlot for curve fitting and analysis (see Figure 35a-b). 
Like that for WT CPR, the kinetic traces for the OHR of G141A CPR were observed to be 
monophasic at each cytochrome c concentration.  Each could be fit well to a single exponential, 
3 parameter equation and the observed rates and relative absorbance changes summarized in 
the table in Figure 35b. The observed apparent rates obtained from the iterative fitting were 
generally slower than those of WT CPR at each relative concentrations of cytochrome c.   The 
values obtained were 1.56, 1.29, 2.52, 3.39, and 5.94 s-1 for 10, 20, 40, 80, and 160 μM 
respectively. Thus, increased reduction rates were again observed with increasing cytochrome c 
concentrations and could be fit to a hyperbolic Michaelis-Menten function.  The derived Kmax 
value (10.7 s-1) was lower than that obtained for WT CPR (15.1 s-1).  Kd for G141A was 69.5 μM 
which was similar to that of 63.1 μM for WT CPR (see Figure 35c). This data suggest that not the 
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electron transfer rate for the G141A variant was somewhat slower than for WT CPR.   This 
demonstration of more activity in WT is also apparent when observing the amount of 
cytochrome c reduced in G141A CPR (see figure 35d). G141A has a maximum reduction of 4.44 
μM of cytochrome c representing only a 54% reduction of the expected stoichiometric 
cytochrome c, whereas WT CPR had 80% reduction. 
 
 
 
 
Figure 34- This equation represents the expected reaction for the OHR in which reduced CPR 
transfers a single electron to an oxidized cytochrome c. The observed rate should be a single 
exponential because the only observable absorbance change occurs as cytochrome c goes from 
oxidized to reduced form in the step with the Kmax label. 
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35b-  
OHR of G141A CPR with Stoich. NADPH + Cyt C- 1 Exp Fit 
    10 uM Cyt C +10 uM NADPH A1 K1 yo 
 
-0.0446 1.559 0.2233 
    20 uM Cyt C +10 uM NADPH A1 K1 yo 
 
-0.067 1.2913 0.3143 
    40 uM Cyt C +10 uM NADPH A1 K1 yo 
 
-0.0693 2.5172 0.3849 
    80 uM Cyt C +10 uM NADPH A1 K1 yo 
 
-0.0622 3.3892 0.4194 
    160 uM Cyt C +10 uM NADPH A1 K1 yo 
 
-0.0703 5.9404 0.7389 
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35c- 
Single Turnover Stopped Flow Experiment with G141A CPR
Single Exp. Fit Data- Michaelis Menten Fit  K
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35d- 
Oxidative Half-Reaction of G141A CPR 
 
Amount of Cyt C 
Reduced (uM) 
Percent Reduction Relative 
to Stoich. Cyt C Reduction 
10 uM Cyt C +10 uM NADPH 3.04 61% 
   20 uM Cyt C +10 uM NADPH 4.43 53% 
   40 uM Cyt C +10 uM NADPH 4.44 54% 
   80 uM Cyt C +10 uM NADPH 3.92 47% 
   160 uM Cyt C +10 uM NADPH 4.34 52% 
   
  
G141A CPR conc.- 16.58uM 
   
   Figure 35- (a) The OHR reaction traces at 550 nm for the various cytochrome c concentrations. (b) The 
values from a single exponential, three parameter fit. (c) A Michaelis-Menten hyperbolic fit of the OHR 
data. (d) Relative amounts of cytochrome c reduced.  
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Oxidative Half-Reaction of G141T CPR- The OHR for G141T CPR was evaluated similarly to 
G141A and WT CPR. Reaction traces along with the fitting to a single exponential, three 
parameter equation and analysis are shown in Figure 36a-b. Inspection of the overlaid reaction 
traces made it clear that G141T was behaving differently than WT or G141A CPR. Most striking 
was the larger absorbance increases observed at 550 nm for the 80 and 160 μM cytochrome c 
OHRs. The shape and extent of the reductive trace at 160 μM cytochrome c was clearly 
different from the others.  The exact cause of the second increase occurring after 10 sec is not 
understood.  This “phase” was not observed at any other cytochrome c concentrations for this 
variant or the others.  It could be a spectrophotometric artifact, but this could not be 
confirmed.  Nevertheless, this part of the reaction occurs at the relatively long timeframe and is 
likely to be catalytically irrelevant so it was ignored for the rest of the analysis.  The rates 
obtained from iterative fitting were slower than those observed in WT and G141A CPR, being  
1.59, 0.76, 2.57, and 3.90 s-1 at 10, 20, 40, and 80 μM cytochrome c, respectively, compared to  
1.91, 1.72, 3.66 and  5.72 s-1 for WT. However, there is still direct relation between cytochrome 
c concentration and rate of reduction, so again a hyperbolic Michaelis-Menten fit was obtained 
(see 36c). Both the Kmax and Kd values appear to be lower for G141T than for WT CPR (9.15 s
-1 
and 54.2 μM, respectively).  However, these values contain substantial error because the actual 
data only define a portion of the fitted hyperbolic curve.  Thus, while the results suggest a trend 
between the G141A and G141T CPR in the OHR, in which the rate of reduction decreases with 
the effect of the Glycine-141 substitution, any such conclusions must be considered tentative at 
this point.  
117 
 
However, the most striking difference that was noted for the G141T CPR variant 
compared to WT and G141A was the total amount of cytochrome c that was reduced at the 
higher concentration of the acceptor (see Figure 36d). At the 10 and 20 μM cytochrome c 
concentrations, the amount of cytochrome reduced was about 73% of what was calculated for 
the stoichiometric reduction by one electron, as was generally observed for the WT CPR.  This 
was expected for a single round of reduction during this type of single-turnover experiment.  
However, at 40 and 80 μM cytochrome c, the level of reduction increased about two-fold to 
158% and 151% of the expected reduction levels associated with a single electron transfer.   
These data suggest that some of the G141T CPR enzyme was able to donate both the electrons 
obtained from the initial reduction by NADPH to the cytochrome c, which is in excess of the 
reductase in these cases.  It can be concluded, therefore, some other mechanism different from 
the simple model in figure 34 is happening and the Glycine-141 alteration is likely the root 
cause of this alternative electron transfer. 
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36b- 
OHR of G141T CPR with Stoich. NADPH + Cyt C- 1 Exp. Fit 
    10 uM Cyt C +10 uM NADPH A1 K1 yo 
550 nm: -0.0524 1.59 0.113 
 
   
20 uM Cyt C +10 uM NADPH A1 K1 yo 
550 nm: -0.0508 0.76 0.215 
 
   
40 uM Cyt C +10 uM NADPH A1 K1 yo 
550 nm: -0.1181 2.57 0.342 
 
   
80 uM Cyt C +10 uM NADPH A1 K1 yo 
550 nm: -0.1148 3.90 0.461 
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36c- 
Single Turnover Stopped Flow Experiment with G141T CPR
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36d-  
Oxidative Half-Reaction of G141T CPR 
 
Amount of Cyt C 
Reduced (uM) 
Percent Reduction Relative 
to Stoich. Cyt C Reduction 
10 uM Cyt C +10 uM NADPH 3.38 73% 
   20 uM Cyt C +10 uM NADPH 3.36 73% 
   40 uM Cyt C +10 uM NADPH 7.32 158% 
   80 uM Cyt C +10 uM NADPH 6.99 151% 
   
  
WT CPR conc.- 9.62uM 
   
   Figure 36- (a) The OHR reaction traces at 550 nm for the various cytochrome c concentrations. (b) The 
values from a single exponential, three parameter fit. (c) A Michaelis-Menten hyperbolic fit of the OHR 
data. (d) Relative amounts of cytochrome c reduced.  
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Oxidative Half-Reaction of G141del CPR: The results obtained for the OHR for G141del CPR are 
shown in Figure 37a-b. Unlike for the other variants, both rate and extent of cytochrome c 
reduction changed with increasing cytochrome c concentrations, but there was no discernable 
correlation between these variables. However, the apparent rates of reduction,1.01, 0.90, 0.53, 
0.47 and 1.12 s-1 for 10, 20, 40, 80, and 160 μM, respectively (Figure 37b), are substantially 
lower than those of WT at all concentrations.  Understandably, these data could not be fit to a 
hyperbolic Michaelis-Menten.  However, the amount of cytochrome c that was reduced by 
G141del CPR was of considerable interest to us.  The amount of cytochrome c reduced was 
observed to be 39%, 105%, 298%, 301%, and 215% of that calculated for a single electron 
reduction process at 10, 20, 40, 80 and 160 μM respectively (see Figure 37c). These data 
strongly suggest that like G141T, G141del CPR is capable of transferring both electrons to two 
cytochrome c molecules. However, this conclusion must be tempered somewhat by some of 
the values being greater than the 200% expected in that case.  The cause of the higher values is 
not known with certainty at this point.  However, the results are intriguing enough to justify 
additional follow-up studies.  If this observation can be substantiated, they suggest that 
electron transfer for this variant, like G141T, is proceeding through a different mechanism than 
WT CPR. 
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37b- 
OHR of G141del with Stoich. NADPH + Cyt C- 1 Exp. Fit 
    10 uM Cyt C +10 uM NADPH A1 K1 C 
 
-0.0209 1.0169 0.0708 
    20 uM Cyt C +10 uM NADPH A1 K1 C 
 
-0.0574 0.9033 0.1729 
    40 uM Cyt C +10 uM NADPH A1 K1 C 
 
-0.1471 0.5338 0.3717 
    80 uM Cyt C +10 uM NADPH A1 K1 C 
 
-0.1528 0.4698 0.4723 
    160 uM Cyt C +10 uM NADPH A1 K1 C 
 
-0.1121 1.1212 0.6392 
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37c- 
Oxidative Half-Reaction of G141del CPR 
 
Amount of Cyt C 
Reduced (uM) 
Percent Reduction Relative 
to Stoich. Cyt C Reduction 
10 uM Cyt C +10 uM NADPH 1.29 39% 
   20 uM Cyt C +10 uM NADPH 3.44 105% 
   40 uM Cyt C +10 uM NADPH 9.75 298% 
   80 uM Cyt C +10 uM NADPH 9.84 301% 
   160 uM Cyt C +10 uM NADPH 7.02 215% 
   
  
G141del CPR conc.- 6.54uM 
 
Figure 37- (a) The OHR reaction traces at 550 nm for the various cytochrome c concentrations. (b) The 
values from a single exponential, three parameter fit. (c) Relative amounts of cytochrome c reduced.  
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Kinetic modeling of the oxidative half-reaction in CPR: The primary fitting of the OHR data for all 
CPR variants made it clear that a neither a single exponential nor a double exponential equation 
could fit the OHR data for all the different concentrations of cytochrome c. This conclusion, in 
addition to the fact that Michaelis-Menten equation could not always provide a satisfactory fit 
to the data and the indication that more than a single electron transfer was possibly present in 
G141T and G141del CPR variants, led to the conclusion that the simple mechanism shown in 
figure 34 was not adequate to describe electron transfer from the flavin cofactors in CPR to the 
final cytochrome acceptor. It was decided to again utilize the KinTek® Global Kinetic Explorer 
software to develop models which could globally fit the absorbance data at 550 nm from the 
OHR at all concentrations of cytochrome c. Just as in the RHR, the established extinction 
coefficients for the different redox species of CPR and cytochrome c were used to generate 
relative absorbance data for the developed models and integration algorithms were used to 
globally fit the multiple reaction traces from each CPR variant. Consequently, microscopic rate 
constants were obtained which aided us in determining what other mechanistic steps might be 
occurring during the transfer of electrons between CPR and cytochrome c, if and how multiple 
electrons were transferred to  cytochrome c for the G141T and G141del variants, and which 
aspects of the OHR mechanism might be affected by the glycine alterations.  
Two kinetics models were developed to explain electron transfer in the OHR. Initial 
fitting was attempted with the simple model shown in Figure 34, but as expected the fits were 
unsatisfactory for all variants of CPR. From this point, two ideas were explored to create the 
final models that were developed. Primarily, we looked at competitive binding of a reduced 
cytochrome c to a reduced CPR enzyme, effectively generating an unproductive complex that 
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prevented reduction of other oxidized cytochrome c molecules. This step is certainly feasible in 
that one can easily imagine that either the oxidized or reduced forms of cytochrome c might 
have similar affinities for the reductase.  Next, we looked at the ability of a single electron 
reduced CPR molecule to bind an oxidized cytochrome c molecule and eventually transfer the 
remaining electron, again, a step that is feasible biochemically. Two different models were 
eventually generated. The first model, called OHR Model Mk.I (Figure 38), was used to globally 
fit the WT CPR and the G141A CPR data and the second model, called OHR Model Mk.II (Figure 
39), was able to globally fit G141T and G141del CPR OHR data.  
 
 
 
Figure 38- This is a cartoon of the OHR Model Mk.I for a two electron reduced CPR. Note that 
there are not two K4 values, rather K4 represents the formation of the complex with CPR(2e-) 
and CytC(red). 
 
 
 
 
Figure 39- This is a cartoon of the OHR Model Mk.II for a two electron reduced CPR. Note that 
K4 represents the formation of the complex with CPR(2e-) and CytC(ox). This model includes 
two different electron transfer steps seen in rate constants K2 and K5. 
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Global fitting of WT and G141A to OHR Model Mk.I : The absorbance traces for WT and G141A 
CPR were very similar in both the observes rates and the fact that, even in excess cytochrome c, 
there was evidence for only a single electron transfer between FMN and the final electron 
acceptor. The similarity between these two variants was confirmed with the kinetic modeling.  
All OHR trials for each of these proteins could be globally fit to the OHR Model Mk.I. The only 
difference between this model and the simple mechanism shown in Figure 34 is the ability of 
reduced CPR to interact with reduced cytochrome c, however this single added step was 
sufficient to achieve accurate fitting (Figure 38).  
The OHRs of WT CPR were the first to be globally fit (see Figures 40a-b). The results 
were not comparable to any of the other CPR variants, because none had been modeled at this 
point, however, the Kd for the reduced CPR: oxidized cytochrome complex and the forward rate 
constant k2+ could be evaluated against the Kd and Kmax, respectively, determined from the 
Michaelis-Menten fit of the WT CPR OHRs. The value of the Kd calculated from the model 
microscopic rate constants k1+ and k1- was 40.2 μM, which compares reasonably well to the Kd 
value of 63.1 μM obtained from the hyperbolic curve fitting previously described. Similarly the 
rate constant k2+ of 12 s-1 is very close to Michaelis-Menten Kmax value of 15.1 s
-1. The other 
equilibrium of particular interest is K4 which generated a Keq value of 1.01 suggesting that the 
binding of reduced WT CPR and reduced cytochrome c is not very prevalent. 
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40a- 
 
Wt CPR and Stoich NADPH and various Cytochrome C - Global fit with OHR Model (Mk.I) 
      Kintek Global Fit Data 
     Rate K1 K2 K3 K4 
 K+ 4.5 12 15 6 
 K- 181 1.3 0.825 6.03 
 
      Kd (uM) 40.2  18.18 1.01 
 Keq (uM)   9.2     
 
      
Molar Extinction Coefficients (μM-1cm-1) CytCox  CPR (2e-) 
CPR (2e-) 
+CytCox  
CPR (1e-) + 
CytCred CPR (1e-)  
      Initially Calculated Values: 0.0089 0.0087 0.0176 0.0344 0.0044 
Experimentally Obtained: 0.0089 0.0087 0.0176 0.0344 0.0044 
       
40b- 
 
 
 
Figure 40- (a) These are the rate constant obtained from the global fitting of the WT CPR OHR 
absorbance traces at 550 nm. (b) This figure represents the global fit of the 10 (red), 20 (blue), 
40 (purple), 80 (yellow) and 160 nm (white) data. The black lines are the data fits and the 
shaded regions on the edges represent data excluded from the global fit.  
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The OHR data for G141A CPR at 550 nm were also globally fit to the OHR Model Mk.I 
(see Figure 41a and 41b). Again to check the accuracy of the model the Kd for the K1 binding 
step and the rate constant k2+ were evaluated against the Kd and Kmax values from the 
Michaelis-Menten fit for this variant. The value of the Kd from the model for the K1 step was 
calculated to be 39.9 μM, which again compares reasonably well to the Michaelis-Menten Kd 
value of 69.5 μM. The value for k2+ of 9.03 s-1 is also similar to Kmax value of 10.7 s
-1 derived 
from the hyperbolic curve fitting.   Thus both analyses suggest that G141A CPR reduces 
cytochrome c somewhat less efficiently compared to WT. A reasonable biochemical explanation 
for this could be that the bulkier methyl sidechain of alanine substitution hinders the proper 
conformational changes needed for formation or positioning FMNsq (and this assertion is based 
on the redox titrations we performed showing lower FMNsq formation in this variant).  
 
 
41a- 
G141A CPR and Stoich NADPH and various Cytochrome C- Global fit with OHR (Mk.I) 
Kintek Global Fit Data 
     Rate K1 K2 K3 K4 
 K+ 3.06 9.03 23.1 119 
 K- 122 0.182 7.14 31.7 
 
      Kd (uM) 39.9   3.24 0.27 
 Keq (uM)   49.6     
 
      
Molar Extinction Coefficients (μM-1cm-1) CytCox  CPR (2e-) 
CPR (2e-) 
+CytCox  
CPR (1e-) + 
CytCred CPR (1e-)  
      Initially Calculated Values: 0.0089 0.0087 0.0176 0.0344 0.0044 
Experimentally Obtained: 0.0089 0.0087 0.0176 0.0344 0.0044 
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41b- 
 
 
 
 
Figure 41- (a) These are the rate constant obtained from the global fitting of the G141A OHR 
absorbance traces at 550 nm. (b) This figure represents the global fit of the 10 (red), 20 (blue), 
40 (purple), 80 (yellow) and 160 nm (white) data. The black lines are the data fits and the 
shaded regions on the edges represent data excluded from the global fit.  
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Global fitting of G141T and G141del CPR variants to OHR Model Mk.II - The larger amount of 
cytochrome c reduced by G141T and G141del CPR suggested that a second round of electron 
transfer to a second cytochrome c maybe occurring in these reductases. Accordingly, the 
observed rates of reduction for the different concentrations of cytochrome could not be fit well 
for G141T or G141del by the Michaelis-Menten equation. With these two observations, it is 
understandable that the mechanism of electron transfer in these two variants was more 
complicated than the basic equation in Figure 34. In fact, these data could not be adequately fit 
to the OHR Model Mk.I particularly at the low cytochrome c concentrations. Therefore, the 
OHR model Mk.II was then constructed to account for the two rounds of electron transfer that 
seems to be observed in these two variants.  
 The OHR data for G141T CPR were the first to be globally fit to the Mk.II model (see 
Figure 41a and 41b). Since a Michaelis-Menten hyperbolic fit was performed on the data, the Kd 
for K1 binding step and rate constant k2+ were evaluated against the Kd and Kmax. The Kd for the 
K1 equilibrium was 109 μM which was about two fold higher than the Kd of 54.2 μM. So the 
correlation was less convincing than those of WT and G141A CPR, however, this does hint at 
relatively inefficient binding of oxidized cytochrome c. The k2+ value of 26.3 s-1 also was at least 
two-fold higher than the Kmax of 9.15 s
-1. The K4 and K5 values for this Model do suggest that 
that the binding of an oxidized cytochrome c to a single electron reduced G141T CPR and the 
subsequent transfer of the electron from the FMNsq is possible. But the analysis of these rate 
constants and using KinTek software to simulate the formation of each species in the OHR 
indicated that the second electron transfer happens infrequently compared to the first electron 
transfer from a two electron reduced CPR molecule. The fitting for this mechanism does contain 
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a certain amount of error as can be seen by the difference in the experimentally obtained 
extinction coefficients at 550 nm for the fully reduced CPR species. In order to obtain 
satisfactory global fits, a certain amount of variation had to be allowed for these values and it is 
suspected that much of this error comes from the 10 and 20 μM cytochrome c OHRs where 
turnover activity by the enzyme is less likely. 
 
42a. 
 
 
 
 
G141T CPR and Stoich NADPH and various Cytochrome C- Global fit with OHR (Mk.II) 
    
         Kintek Individual Fit Data 
        Rate K1 K2 K3 K4 K5 
   K+ 0.453 26.3 38.3 1.1 4.82 
   K- 49.4 5.9 2.62 0.0497 36.1 
   
         Kd (uM) 109.1   14.62 0.05   
   Keq (uM)   4.5     0.1 
   
         
Molar Extinction Coefficients (μM-1cm-1) CytCox  CPR 2e- 
CPR 2e- 
+CytCox  
CPR 1e- 
+ 
CytCred CPR 1e-  
CytC 
Red  
CPR 1e- 
+ Cyt C 
Ox 
CPR ox 
+ CytC 
red 
Initially Calculated Values: 0.0089 0.0087 0.0176 0.0344 0.0044 0.0299 0.0133 0.0299 
Experimentally Obtained Values: 0.0089 10uM - 0.0066 0.0176 0.0344 0.0044 0.0299 0.0133 0.0299 
  
20uM - 0.0141 
      
  
40uM - 0.0033 
      
  
80uM - 0.0062 
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42b. 
 
 
Figure 42- (a) These are the rate constant obtained from the global fitting of the G141T OHR 
absorbance traces at 550 nm. (b) This figure represents the global fit of the 10 (red), 20 (blue), 
40 (purple), and 80 (yellow) data. The black lines are the data fits and the shaded regions on the 
edges represent data excluded from the global fit.  
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 The OHR Model Mk.II was used to fit the OHR for G141del CPR (see Figure 42a and 42b). 
For this variant, the OHRs with 40, 80, and 160 μM cytochrome c all showed more than twice 
stoichiometric level of cytochrome c reduction as was discussed previously. The Model Mk.II 
takes into account the ability of G141del to transfer the second electron and consequently this 
model could more accurately fit the OHR time courses at all concentrations of cytochrome c. 
Because the Michaelis-Menten hyperbolic equation could fit the G141del OHR data, Kd and Kmax 
values specific to the deletion variant could not be established for comparisons. An assessment 
to the other variants shows that the Kd of the K2 step for G141del (85.5 μM) is comparable to 
WT and G141A (40.2 and 39.9 μM, respectively) and most similar to G141T CPR (109 μM). The 
k2+ value is the slowest for any variant at 8.22 s-1 and this correlates well to the observed rates 
of reduction from single exponential fitting which were also the slowest for G141del. The most 
striking conclusion from the global fitting to the Mk.II mechanism comes from inspection of the 
K4 and K5 values and the comparison of these values for the G141T variant. The k4+ value for 
G141del is greater than three-fold higher than that of G141T, illustrating greater occurrence of 
binding between the single electron reduced enzyme and a cytochrome c. The K5-associated 
values represent the major difference between the G141T and G141del and explain the ability 
of this variant to reduce two equivalents of cytochrome c. The k5+ has a value of 396 s-1 which 
is 80-fold higher than G141T and Keq value of 60.7 μM shows that not only is the second 
electron transferred very rapid after binding, but it is favored in the equilibrium. These 
conclusions suggest a possible connection between the RHR and the OHR. It was seen in the 
RHR that G141del, unlike the other CPR variants, favors the rapid transfer of both electrons to 
the FMN cofactor. Since the FMN cofactor is the donor of electrons to cytochrome c, the full 
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reduction of the FMN could support the transfer to two cytochrome c molecules without any 
additional inter-flavin electron transfers. However, in WT CPR the FMNsq is the electron donor 
and the transfer of a second electron is not favorable. This fact in mind, the glycine alteration 
destabilizes the FMNsq (as demonstrated by redox titrations) and in the case of G141del causes 
only transient formation of the FMNsq (seen in the RHRs), presumably allowing not only the full 
reduction of the FMN, but also efficient transfer of these two electrons to the cytochrome c. 
Fitting to the OHR model Mk.II shows this same phenomenon is seen in G141T CPR which also 
has a destabilized FMNsq. However, the smaller overall effect of bulkier sidechain of threonine 
(compared to the affect of the deletion of the glycine) represents a smaller propensity to 
transfer this second electron. 
  
43a- 
G141T CPR and Stoich NADPH and various Cytochrome C- Global fit with OHR 
(Mk.II) 
    
         Kintek Individual Fit Data 
        Rate K1 K2 K3 K4 K5 
   K+ 3.52 8.22 1.6 3.92 396 
   K- 301 2.06 7 0.512 6.52 
   
         Kd (uM) 85.5  0.23 0.13  
   Keq (uM)   4.0     60.7 
   
         
Molar Extinction Coefficients (μM-1cm-1) CytCox  CPR 2e- 
CPR 2e- 
+CytCox  
CPR 1e- + 
CytCred CPR 1e-  
CytC 
Red  
CPR 1e- 
+ Cyt C 
Ox 
CPR ox 
+ CytC 
red 
Initially Calculated Values: 0.0089 0.0087 0.0176 0.0344 0.0044 0.0299 0.0133 0.0299 
Experimentally Obtained Values: 0.0089 10uM- 0.025 0.0176 0.0344 0.0044 0.0299 0.0133 0.0299 
  
20uM- 0.0176 
      
  
40uM - 0.0103 
      
  
80uM - 0.0109 
      
  
160uM- 0.026 
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43b- 
 
 
Figure 43- (a) These are the rate constant obtained from the global fitting of the G141del OHR 
absorbance traces at 550 nm. (b) This figure represents the global fit of the 10 (red), 20 (blue), 
40 (purple), 80 (yellow) and 160 nm (white) data. The black lines are the data fits and the 
shaded regions on the edges represent data excluded from the global fit.  
 
 
 
 
 
Time (sec) 
R
el
at
iv
e 
A
b
so
rb
an
ce
 
135 
 
Summary and Conclusions 
The majority of the specific analyses of the results of experiments performed in this 
thesis were discussed in the corresponding results sections. This section will serve as a 
summary of performed experiments, discussion of the most pertinent results, and examination 
of our conclusions in a broader context. 
 Steady-state turnover assays of CPR with NADPH and cytochrome c showed significant 
differences between the cytochrome reductase activities of the CPR variants. WT CPR 
had an activity of 3900 s-1 and compared to this benchmark G141A CPR had 118% 
activity, G141T had 72% activity, and G141del CPR had 44% activity. The increased 
activity of G141A CPR was determined not to be statistically significant, however, the 
reduced activity of G141T and further reduced activity of G141del was attributed, at 
least in part, to the destabilization of the FMNsq by the glycine alterations because the 
FMNsq is generally thought to be the electron donor to the terminal cytochrome 
acceptor.   
 The FAD-dependent ferricyanide reductase activity was observed to be altered in the 
glycine variants. Compared to WT all variants displayed decreased activity (86% for 
G141A, 61% for G141T, and 62% for G141del CPR. These results were perplexing 
because it is widely held in this field that ferricyanide reductase activity resides 
exclusively with the FAD-binding domain, which should remain unaltered in all CPR 
variants because the glycine alterations were introduced in the separate FMN-binding 
domain.  These results, and other unpublished results from this laboratory, do suggest 
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that the FMN-binding domain might be exerting some influence on the transfer of 
electrons from NADPH to ferricyanide through the FAD cofactor, however.  The 
molecular basis of this effect is not understood currently, but could benefit from further 
study using this group of CPR variants and others generated in this laboratory.  
 Anaerobic redox titrations clearly demonstrated that the highly conserved glycine in the 
FMN-binding loop as identified by homology to other similar proteins affects the 
thermodynamic stability of the “blue” neutral FMNsq species.  Accordingly, FMNsq 
stability appeared to directly correlate to the extent of alteration of the Glycine-141 
residue. Relative to WT CPR, G141A had 80%, G141T had 72%, and the G141del FBD had 
basically undetectable (<10%) accumulation of neutral FMNsq.  These results are 
consistent with previous studies in this laboratory on the bacterial flavodoxin.  Those 
studies provide compelling evidence that the introduction of the sidechain, one even as 
modest as the methyl group of alanine, can influence the interaction made between the 
backbone carbonyl of the residue at this position (glycine in WT) and the N(5)H of the 
FMNsq.  The FMN domain in CPR is similar in structure to the flavodoxin and, based on 
the results reported here, also likely stabilizes the neutral FMNsq in a similar manner.  
Because of the central role of the FMNsq species in electron transfer to cytochromes by 
this reductase, the focus of my research then became elucidating the specific 
mechanistic consequences of these differences in stability.  
 The primary in depth study performed was the reductive half-reaction which observed 
transfer of electron for NADPH to the FAD and then between FAD and FMN. The 
absorbance data from these experiments showed a triphasic reduction for all variants of 
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CPR at stoichiometric and excess levels of NADPH.  The third and slowest phase, 
involved only small absorbance changes and was deemed to be too slow to be 
catalytically pertinent, was discounted from further discussion.  However, the two initial 
faster phases involved substantial absorbance changes and occurred in a timeframe to 
be of relevance.  As was anticipated from the anaerobic titrations although using 
artificial electron donor/acceptors (dithionite and/or ferricyanide), the disemiquinoid 
species was seen to accumulate in these single-turnover experimental conditions with 
stoichiometric amounts of the added physiological electron donor NADPH for the WT, 
G141A, and G141T variants.  In marked contrast, the G141del RHR at demonstrated only 
transient formation of the neutral disemiquinoid species presumable with both 
electrons derived from the NADPH ultimately residing in the FMN cofactor.  These 
results are consistent with the absence of the accumulation of the neutral FMNsq 
during anaerobic titrations of the isolated FMN domain from this variant. The 
mechanistic implications of this observation were of significance during the evaluation 
of the OHR. 
 To better understand the reaction traces and mechanism of the RHR and the disparity 
between G141del and the other variants, kinetics models were made to globally fit the 
absorbance traces and to eventually elucidate the electron transfer process. In 
particular, these modeling studies were found to be essential in explaining the 
enigmatic biphasic formation of the disemiquinoid species which could not be explained 
by a simple reduction mechanism.  The first and major phase was clearly ascribed to the 
hydride transfer from NADPH to the FAD and the subsequent very rapid formation of 
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the disemiquinoid state.  The second (and possibly third) phase could not be assigned to 
any one specific electron transfer step, but rather was described a combination of 
several microscopic rate constants relating a variety or electron transfers.  
 Two different mechanisms of electron transfer mechanism for the RHR were established 
by comparison of the variants to WT CPR. The first mechanism showed that in WT, 
G141A, and G141T there was preferential formation of the disemiquinoid state, with or 
without the NADP+ bound to the enzyme. In stark contrast, electron transfer in the 
G141del variant results in the ephemeral formation of the disemiquinoid before the 
NADP+ is released and a second electron moves from FADsq to FMNsq, fully reducing 
the FMN cofactor. The difference in electron transfer here has to do with the very stable 
formation of the FMNsq, which in WT CPR appears to serve as a “road block”, so to 
speak, for the transfer of a second electron to FMN. The G141del served as the 
contrasting model where loose binding to the inflexible peptide loop causes unstable 
FMNsq formation, allowing the FAD to immediately and rapidly transfer a second 
electron. G141A and G141T CPR, with their relative instability of FMNsq have 
mechanism somewhere in between those of WT and G141del CPR in which the majority 
of the time only a single electron transferred from FAD, but occasionally there is the 
opportunity to fully reduce FMN. 
 The study of the oxidative half-reaction provided information on the second half of the 
steady-state turnover process associated with the cytochrome reductase activity of CPR. 
The expected result of this experiment for CPR was a single electron transfer from the 
FMNsq to a bound, oxidized cytochrome c, effectively reducing stoichiometric amounts 
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of cytochrome c as was observed for WT and G141A.  However, G141T and G141del 
demonstrated the ability to reduce more than one equivalent of cytochrome through an 
additional round of the electron transfer utilizing the second and last electron derived 
from NADPH.  Two separate mechanistic models were developed: (1) the Mk.I model 
which could globally fit the WT and G141A CPR data and revealed the possibility of 
competitive binding between reduced and oxidized cytochrome c on the FMN-binding 
domain of CPR and (2) the Mk.II model which was used in globally fitting the G141T and 
G141del OHR.  The fitting to the Mk.II model accounted for the possibility of these 
enzymes (in their one electron reduced form) to bind and reduce a second cytochrome 
c. Although satisfactory fits were achieved using these mechanisms it does seem 
reasonable that in actuality the most correct mechanism would be better approximated 
with a combination the Mk.I and Mk.II models, where a huge number of chemical 
interactions are happening all at the same time. There was insufficient time to pursue 
this possibility. 
 Completing analysis for the reductive and oxidative half-reactions has led us to think 
about likely connections between these two electron transfer processes. We began to 
hypothesize about how the unique RHR of G141del CPR could account for the ability of 
this enzyme to uncharacteristically transfer both of its electrons to cytochromes (this 
analysis would also apply, to a lesser degree to G141T CPR). Although the exact 
molecular mechanism of electron transfer is yet to be established for WT CPR, the 
available structural data provides a paradox.  X-ray crystal structures of the reductase 
shows that the FMN-binding domain is closely associated with the FAD-binding domain 
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in a manner that places both flavin cofactors within van der Waals contact, a 
configuration ideal for efficient inter-flavin electron transfer.  However, this 
conformation would seem to preclude access of the FMNsq to the cytochrome for 
electron transfer.  This laboratory and others have hypothesized and are working to 
provide experiment support for a mechanistic model that involves the movement of the 
FMN-binding domain away from the FAD cofactor prior to transfer of electrons from the 
FMNsq to the cytochrome. Such a domain movement would be facilitated by the 
flexible polypeptide “hinge” region that connects the two domains.  Indeed, there is 
experimental evidence for this movement, but this has yet to be linked with electron 
transfer and reductase activity in this enzyme.  Given this model, the transfer of two 
electrons from WT CPR to two cytochrome molecules would then requires two domain 
movements. Furthermore, the thermodynamic stability of the two flavin semiquinone 
states in WT CPR may inhibit the process of the transfer of the second electron further, 
especially if domain movement is also involved.   It is very intriguing to suggest that 
unlike the WT reductase the ability of G141del CPR, and perhaps to a lesser extent the 
G141T variant, to much more rapidly transfer the second electron from the FADsq to 
the FMNsq as demonstrated in this study and simulated and fit to the RHR Full Model 
(see k10+ values), could then allow for the formation of the FMNhq prior to domain 
movement. This FMNhq could then sequentially bind and transfer electrons to two 
cytochromes in a manner similar to the OHR Model Mk.II.  We believe that this 
observation represents an important basis for a fundamental hypothesis regarding the 
details of electron transfer for this and perhaps other diflavin reductases.  This 
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hypothesis, and many additional ones, represents questions currently being explored in 
this lab. 
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